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ABSTRACT

Herpetic Stromal Keratitis (HSK) is a leading cause of infectious blindness resulting
from corneal infection with herpes simplex virus (HSV-1 ). Extensive corticosteroid
therapy is required to achieve remission and sometimes corneal transplantation is the
only means of restoring vision. Murine model research has revealed that the
immunological process that clears infection conversely leads to corneal tissue
damage. This immuno-pathological reaction involves complex interactions of cellular
and molecular events.
Current knowledge about human and murine HSK pathogenesis is
summarized in Part I. Parts II, III and IV progresses this knowledge using knockout
and transgenic mice. Results in Part II clarify mechanisms that operate shortly after
corneal infection using a mouse with defective neutrophil migration. Impaired corneal
neutrophil migration delayed corneal viral clearance causing heightened inflammation
in the c ornea. The c ytokine IL-6, a component of this response, was shown to be
capable of inducing VEGF, resulting in an increased angiogenic response and
enhanced HSK lesions. These results provide novel insights into the link between
viral infection, pro-inflammatory molecules, neutrophil migration, angiogenesis and
HSK development. The role of HSV reactive and non-reactive CD8+ T cells in HSK
pathogenesis is discussed in Parts III and IV. It has been demonstrated that CD4+ T
cells, crucial to the development of HSK, do not require HSV antigen recognition to
mediate HSK. Instead they are activated and recruited to the cornea by bystander
mechanisms apparently through the action of pro-inflammatory molecules. Our recent
iv

results indicate that bystander mechanisms also facilitate corneal recruitment of non
HSV specific ens+ T cells. However, HSV reactive ens+ cells were not involved
directly in corneal lesions but instead modulated lesion severity and protecte mice
from lethal H SV i nduced e ncephalitis. T his latter e ffect a ppeared t o b e d ue t o the
ability of HSV specific ens+ T cells to control viral replication in the peripheral
nervous system and thereby prevent spread to both the brain and the cornea.
This dissertation presents research aimed a t elucidating both molecular and
cellular events in HSK pathogenesis. These results will serve as guidelines for future
development of more efficient prophylactic and therapeutic strategies.
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BACKGROUND AND OVERVIEW

1

Information provided in this chapter is a revised version of a review article by
Kaustuv Banerjee and Barry T Rouse, submitted for publication as a chapter in the

book:

Banerjee, K and Rouse, B. T. (2004). Immunopathological aspects of HSV infection.
In Pathogenesis, Host response and Clinical Disease. Human Herpes Viruses:

Biology, Therapy and lmmunoprophylaxis. Eds: A. Arvin, G. Campadielli-Fiume, P .
Moore, E . Mocarski, B. Roizman, R . Whitley and K. Yamanishi. Cambridge
University Press.

My contributions in the review article include (1) literature survey (2) compilation of
information (3) plan review outline (4) writing (5) preparation of figures and
manuscript editing.

INTRODUCTION

Foreign material entering multicellular organisms triggers a range of defense reactions
which, when successful, subjugates and removes the invaders. Invertebrates and
plants suffice with natural defense systems, which recognize commonly shared
patterns and usually react in a stereotypical manner. Long-lived animals such as
vertebrates add to these natural defenses with adaptive systems that show
discriminating recognition machinery, complex and varyi_ng effector mechanisms and
an ability to learn from . experience. ·Under ideal circ�mstances, immune defense
proceeds with minimal or inapparent damage to the host itself. In other situations, the
defense system is less successful and the host tissues become damaged by the

2

reaction. We usually consider the former situation as immunity and the latter as
immunopathology. However, in both instances, mechanisms at play may be similar.
With

microorganisms,

the

commonest circumstance that results

in

immunopathology is where the microbe persists and continues to cause an innate and
adaptive response. These, however, prove ineffective to remove or neutralize the
agent. Thus the reaction becomes chronic and host tissues become damaged as a
consequence. This situation occurs in tuberculosis as well as hepatitis B and C virus
infections. Over time many microbes with a long association with a host species find
ways of persisting by evading responses that would either reject them or cause too
much tissue damage. Human CMV infection in immuno-competent adults provides an
example of this scenario ( 1 ) Other circumstances that result in immunopathology
.

involve settings where one or more components of normal immune defense are
compromised for genetic or other reasons. Prolonged severe genital herpes simplex
virus (HSV) lesions in AIDS patients with very low CD4+ T cells represent such an
example (2). Atopies too often have problems clearing HSV and hence often develop
skin and eye lesions (3). In addition, some microbes are considered as able to trigger
immune r eactions that target h ost c omponents t hemselves ( autoimmune disease) or
cause infected cells to undergo neoplastic transformation. The herpesvirus EBV
provides an example of the latter in genetically susceptible individuals (4). There are
no undisputed examples wherein herpesviruses cause autoimmune diseases. However,
circumstantial evidence exists for HHV-6 causing multiple sclerosis ( 5) and possibly
HSV infection causing an autoimmune corneal inflammatory lesion (6). This later
model is discussed in more detail subsequently.
Herpes simplex virus is a pathogen that only rarely appears as involved in
immune mediated tissue damage. Characteristically, primary or recurrent infections at
3

superficial mucosal or dermal sites result in viral replication and destruction of most
cells that support infection. This process induces an innate inflammatory reaction that
contributes to infection control. Some cells, likely Langerhans dendritic cells, leave
the site and carry viral antigens to draining lymph nodes where an adaptive response
is induced or recalled. After a few days, effectors of adaptive immunity are recruited
to the site, initially CD4+ T cells followed by CD8+ cells, and these T cells, probably
assisted by antibody, complete the task of recovery (2). Virus is removed and the
inflammatory reaction subsides usually without trace. These events can be judged to
represent immunity. As already mentioned, when aspects of T cell function is
impaired, as can happen in AIDS patients, HSV removal is impaired a�d the
inflammatory reaction becomes unusually severe and prolonged. This situation can be
taken to represent immunopathology.
Certain tissue sites are particularly vulnerable to damage by an inflammatory
response. These are sites where virus is difficult to dislodge, so the inflammatory
reaction becomes prolonged and destructive, or where tissue repair leaves a
·

functionally damaged organ. The best site which exemplifies such circumstances is
the eye. In this organ, where inflammation or scar tissue along the visual axis impairs
function, HSV infection may permanently impair vision. The most frequent example
is herpetic stromal keratitis (HSK). This chronic inflammatory reaction damages the
stroma and can become sufficiently severe to merit corneal transplantation. About
20% of ocular HSV infections in humans result in stromal keratitis (7). In most
instances, these are caused by HSV -1 and result from reactivation from latent
infection in the trigeminal ganglion (7). Most of our understanding of the
immunopathogenesis of HSK comes from studies in animal models, in former times
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mostly the rabbit and now most usually the mouse. These studies are discussed
subsequently.

HERPES INFECTIONS AND OCULAR DISEASE

At least four human herpesviruses have been implicated as causes of ocular disease.
Two alphaherpesviruses, HSV and Varicella Zoster virus (YZV), the betaherpes virus
CMV and the gammaherpesvirus EBV. CMV is a cause of retinitis, a lesion found
only i n i mmunosuppressed individuals, the majority o f w hich were formerly A IDS
patients, but now transplant recipients, especially recipients of bone marrow (8). With
the widespread use of protease inhibitors to control HIV, CMV retinitis is now mainly
a disease of transplant recipients. The lesion itself is likely a direct consequence of
viral replication in retinal cells. EBV is an occasional cause of HSK lesions. These are
characterized by an abundance of lymphoma like cells, in the stroma that are
presumed to be mainly B cells. (9).
More commonly both HSV and VZV cause lesions in the anterior segment,
principally the cornea. These lesions, many of which are immunopathological are
discussed in the following sections.

KERATITIS IN HUMANS

Both HSV and VZV can infect multiple structures in the eye. Lesions caused by HSV
are much more common. The incidence of HSV ocular disease ranges from 4. 1 -20.7
cases/1 00,000 patient years representing the commonest single infection cause of
vision impairment in the western world (7). Of the three general types of HSV corneal
disease, Infectious Epithelial Keratitis (IEK) is the most common lesion and this
5

appears to be a result of the direct effect of viral infection. Both disciform keratitis
(HSV endotheliitis) and HSK are thought to be mainly the consequence of immune
mediated mechanisms rather than by direct viral damage. Lesions seen with IEK are a
result of viral replication and spread in the superficial epithelial layer of the cornea.
This condition is usually self-limiting· and no permanent corneal damage results. The
quick remission seen with timely antiviral therapy suggests a simple viral cytolytic
mechanism. However, virus invariably infects nervous ramifications in the cornea that
have free ends within the epithelial layer, thus allowing retrograde transport and
latency establishment (10). In addition, as a consequence of epithelial damage, virus
can spread to the underlying stromal keratocytes and cause what is usually termed as
necrotizing form of stromal keratitis (11) This terminology does not fit well with
.

many ophthalmologists since necrosis also occurs in immune mediated HSK.
Disciform keratitis (DK) is a lesion in which the corneal endothelium is the
primary site of damage. This form of ocular disease appears immunopathological
based upon the fact that early inter\rention with corticosteroids leads to complete
resolution (11). In DK, the inflammatory reaction of the endothelium sometimes
results in secondary stromal and epithelial edema but there is usually no stromal
infiltrate o r neovascularization. 0 ne o f the c haracteristic f indings in patients i s t he
demonstration of keratic precipitates or KP (11). The exact nature of the KP is
unknown but they could be aggregates of macrophages or NK cells attracted by the
immunoglobulins on the cell surface of infected cells (11). An alternative idea is that
KP

represents cytotoxic T cells recognizing viral epitopes on the endothelial cells

(11). The role of live virus in disease development is supported by finding antigens,
live virus and DNA in the anterior chamber and perhaps also corneal endothelial cells
(12, 13). It has been postulated that productive infection of the endothelial cell elicits
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a cellular and humoral immune response ( 1 4) , but this evidence is only circumstantial.
Alternative s uggestions include a p ossible delayed type hypersensitivity r eaction t o
persisting HSV antigens within the stroma or the endothelium (15). It is difficult to
resolve the nature of DK pathogenesis since animal models to study it are less than
ideal. D isciform d isease i s s een i n r abbits w ith an intracorneal i njection of soluble
viral antigen ( 1 6). Using the rabbit model for DK some have suggested the lesions to
involve

immune

complex

formation

and

antibody-dependent

cell-mediated

cytotoxicity (17).
Inflammation of the corneal stroma (HSK) as a result of HSV-1 (rarely HSV2) infection can lead to a blinding immuno-inflammatory lesion of the stroma. This
only accounts for approximately 2% of initial episodes of ocular disease but
approximately 50% of recurrent ocular HSV disease (18). A similar, but even more
devastating lesion can be caused by VZV infection. Fortunately, this is quite rare and
also usually occurs as a consequence of reactivation (zoster). They usually heal
quickly unless the patient is immuno-suppressed (19). Recurrent lesions can be very
severe and most difficult to treat and control. Frequently, corneal lesions are
accompanied by conjunctivitis, anterior uveitis and lipid keratopathy (19). If the virus
is not controlled, it spreads to involve the iris and the corneal stroma. Stromal lesions
can become sclerotic and very persistent and is believed to be immune mediated,
however, the mechanism is not known and is d ifficult to study. Patients often lose
sensitivity of the cornea and involuntary physical damage can result in secondary
bacterial infection.
Several observations suggest the operation of an immune etiology behind HSV
induced HSK. These include the fact that the lesions are persistent and are manifest
well beyond the time that virus or viral antigens can be demonstrated. Lesions often
7

need to be managed with indefinite corticosteroid treatment and reactivation lesions,
except initially, do not benefit from acyclovir antiviral treatment. Also making a case
for the pathogenesis of HSK involving immunopathology is the fact that the lesion is
very uncommon in immuno-suppressed patients. Finally, clones ofT lymphocytes
reactive to viral epitopes and possessing cytotoxic activity can be cultured from
corneas showing chronic HSK lesions (20, 21).
Approximately 90% of patients maintain good visual acuity despite prolonged
disease. However, in many cases resolution of inflammation is associated with a
permanent loss of vision resulting from corneal scarring and ulceration. This
necessitates treatment by corneal transplantation, which in itself can sometimes be a
high risk factor for recrudescent herpetic keratitis (also called newly acquired herpetic
keratitis) (22) and super-infection with a different strain (23)
The corneal stroma may be affected by several mechanisms; this may be
secondary t o d isease o f the epithelium ( IEK) o r e ndothelium ( DK) o r as a stromal
edema resulting f rom a d amaged endothelium. I n humans, HSK m anifests i tself i n
two primary forms that are perhaps mis-termed necrotizing HSK and immune HSK
(11). While the former is thought to result from direct viral invasion of the stroma,
chronic immune mechanisms, possibly of an autoimmune nature (yet unproven), are
the suspected culprits in pathogenesis of the latter (7). These divisions are not
mutually exclusive and necrosis can definitely occur in the immune form. Intact
virions and antigens can be detected in corneal keratocytes, endothelial cells and foci
of epithelial cells in specimens from patients with acute (necrotizing) stromal keratitis
(24, 25). This suggests that replicating virus and the resulting host inflammatory
response leads to stromal cell destruction. This acute necrotizing form of HSK
eventually may become chronic, then considered as immune form of HSK, when viral
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antigens are no longer present. The signs of HSK are generally quite variable but they
involve the influx of a large number of different kinds of cells including
polymorphonuclear leukocytes (PMN), macrophages, Langerhan's cells, natural killer
(NK) cells, plasma cells and T lymphocytes (26-29). In chronic HSK in humans the
predominant population are macrophages and T lymphocytes (27). Excess
neovascularization also occurs in some patients.
The original mechanism proposed for the pathogenesis of the immune form of
HSK focused on the role of anti-HSV antibodies. This was based on the finding that
rings (Wessely rings) seen in the mid-stroma of the cornea in immune stromal
keratitis were positive for lgM, IgG and IgA (30). Herpes virus particles have been
demonstrated in these rings, many of them defective or incomplete (30). In addition,
viral antigens have been found localized in the keratocytes of the corneal stroma in
transplanted corneas (28, 3 1 ). Hence it has been speculated that viral antigens trapped
in the stroma acted as a nidus for deposition of anti-HSV antibodies that fixes
complement and leads to cellular damage (7). Viral antigens can also be presented to
the infiltrating T lymphocytes. In clinical specimens, increased levels of class I and II
HLA antigens have been n oted i n a reas of t he g reatest infiltrate, suggesting a ctive
presentation of antigens (26). Both CD4+ and CD8+ T cells occur in chronic HSK with
the former dominating the total T cell numbers (28). Most of these cells are reactive
against HSV antigens with the CD4+ subset reactive to peptide epitopes from UL2 1
and UL49 tegument proteins of HSV (20, 2 1 ). They do not apparently recognize
antigens derived from corneal tissues which would provide evidence for an auto
immune m echanism ( 20). Corneal d erived C D4+ c ells h ave b een shown t o p ossess
cytotoxic activity suggesting the possible operation of this mechanism in stromal cell
injury (20, 2 1 )

.
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ANIMAL MODELS FOR HSK

Understanding the pathogenesis of human HSK must rely only on clinical
observations, transplant material and the occasional samples obtained at biopsy. Not
.
surprisingly with such data it is difficult to construct a coherent understanding of HSK
pathogenesis. Fortunately, convenient animal models exist wherein HSV infection of
the eye reproducibly generates a stromal inflammatory response. Moreover, this
appears to reflect human immune HSK at least prior to aggressive treatment. The
usual animal models are the mouse and rabbit with the latter now rarely used except
for s tudies o n t herapy. U nderstanding e vents i nvolved i n H SK pathogenesis comes
mainly from studies of primary infection i� various mouse strains. Since human HSK
is most commonly a sequel to reactivated infection, a better animal model should be
one where lesions follow reactivation. Such models have in fact, been described for
both mice and rabbit (32, 33) but these are expensive and inconvenient and have
contributed minimally to the understanding of pathogenesis. Rabbit reactivation can
be achieved by ocular iontophoresis but this seldom gives rise to HSK lesions (32).
The mouse reactivation model can be achieved by infecting mice under a cover of
neutralizing antibody, then after some weeks asymptomatic animals are exposed to
UV

light. In usually a minority of animals, virus reactivates and generates an

inflammatory reaction in the stroma (33). Few papers have employed the model, and
the results of these usually support the basic findings of the primary infection model;
namely that HSK is an immuno-inflammatory lesion mainly orchestrated by CD4+ T
cells (34).
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The primary infection model usually uses strain HSV

-

1 RE

and involves virus

application to a lightly scratched cornea. Replication begins in epithelial cells of the
cornea and usually the conjunctiva, but in immuno-competent mice rarely spreads to
involve stromal cells or cells in uveal tissue. Characteristically, the viral replication
events are over by 5-6 days and viral gene expression, as judged by protein detection
or viral mRNA, are undetectable beyond a further 2-3 days (3 5). Viral DNA,
however, can be detected for prolonged periods although copy numbers, detectable by
real-time P CR, d o n ot e xceed 2000 - 5000 copies p er c ornea by 1 4 d ays p .i. ( our
unpublished results).

When looked at with an ophthalmoscope, the initial viral

replication events are accompanied by a barely detectable inflammatory reaction with
new blood vessel growth from the limbus (the location of blood vessels at the edge of
the vessel free normal cornea) the most obvious feature. This is often referred to as
the pre-clinical phase, although in fact with appropriate tests is readily observable.

Innate immune response to infection in the mouse model

HSV infection of the corneal epithelium sets off a range of humoral and
cellular events that taken together help contain infection. Unfortunately, some of these
also set the stage for subsequent immunopathology. A prominent early cellular event
is the influx of polymorphonuclear neutrophils (PMN). This occurs mainly into
stromal tissues s ubjacent to the i nfected epithelium. S uch P MN e scape from b lood
vessels at the limbus presumably in response to signaling molecules generated from
virus infected cells. The nature of such signaling molecules is unclear but several
chemokines, including those known to be chemotactic to PMN, can be demonstrated
within 1 2

hr p.i.

(3 6, 37)
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The PMN response is at its peak around 48 hrs and it seems that this response
helps control viral replication. Thus depleting PMN with specific monoclonal
antibodies results in more intense and prolonged virus infection in the cornea (37, 38).
Moreover, PMN suppressed animals may succumb to encephalitis since virus now
spreads to the brain . . Such observations indicate that PMN are part of the anti-viral
defense system although it is unclear how this function is performed. Accordingly,
virus infected cells and PMN are usually not in direct contact implying that the
protective function is indirect. Ideas for the mediation of such defenses include

IFNy

and TNFa production as well as nitric oxide production by PMN (39). This topic has
not been fully explored using, for example, knockout mice and other means of
implicating potential anti-viral mechanisms.
The P MN r esponse t o virus is n ot only a d efense r eaction. I ndeed p roducts
released from PMN have been proposed to contribute to corneal damage possibly
unmasking auto-antigens subsequently involved in the immunopathology (3 7). In
addition, PMN contribute to the process of neovascularization, a prominent feature of
HSK and a necessary step in its pathogenesis (40, 41 ). It appears that PMN may be a
source o f a ngiogenesis factors such as V EGF as w ell a s tissue d egrading enzymes
which breakdown the stromal matrix and facilitates the growth of new blood vessels.
One such enzyme released by the granules of activated PMN is MMP9 (42). Since
infected mice given the MMP-9 inhibitor TIMP-1 as well as MMP9-/- mice have
reduced angiogenic and SK responses, MMP9 appears to be intricately involved in
HSK pathogenesis (42).
Although PMN dominate the early inflammatory reaction to ocular HSV
infection, other cell types can also be demonstrated. These include macrophages,
dendritic cells (DC), NK cells but not B or aJ3 TCR T cells. The roles for these other
12

cell types have received minimal investigation. It is likely, however that the
macrophage is a source of angiogenic factors such as VEGF and FGF as well as the
angiogenic CXC chemokines. Some of these c hemokines may also be involved in
facilitating neutrophil influx. Thus, in vivo neutralization of MIP-2 in HSV infected
mice reduces PMN migration (43). In other models such as in the Onchocerca
volvulus ocular infection model, MIP-2 (CXCL8} appears important since infected

mice lacking the receptor for MIP-2 (CXCR2-/- mice) have an impaired PMN
response (44). Macrophages, along with

DC,

also act as a source of cytokines

demonstrable early after infection. Most prominent of these are IL-l and IL-6, both of
which can also be produced by virus infected epithelial cells themselves (45, 46).
Indeed it could be that these two cytokines are critical signaling molecules responsible
for the many paracrine events set off by virus infected epithelial cells. The other early
events described include the production of iL- 1 2, VEGF and TNFa, but none of these
are thought to be products of virus infected cells themselves (47, 48).
The cytokine IL- 1 2 appears as a pivotal molecule in HSK pathogenesis.
Knockout mice, for example, unable to produce IL- 1 2 have only mild HSK lesions
(49). The source of IL- 1 2 following HSV infection remains to be clarified, since as
mentioned it does not appear to be HSV -infected cells themselves (48). However
conceivably viral DNA that has pathogen associated molecular pattern (PAMP)
activity could represent such a stimulus (50). The most likely producer cell types are
DC and macrophages. The DC initially involved would seem to be the resident cells
only recently demonstrated as present in normal noninflamed corneas (5 1 ). A
prominent feature of the injured cornea, including that caused by HSV, is the invasion
of Langerhans

DC,

likely from the conjunctiva, into the cornea (52). However, this

event takes several days to occur. Likely such cells also act as a source of cytokines
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and c hemokines b ut their m ajor function in HSK p athogenesis i s transport o f viral
antigens to lymphoid tissue where the adaptive immune response is initiated
(discussed later).
The cytokine IL-1 2 has several downstream effects that impact on HSK
pathogenesis. The primary effect is induction of IFNy production by cells with IL- 1 2
receptors. Although not proven in the eye, the most likely cells that respond and
produce IFNy are natural killer (NK) cells. Such cells in non-ocular systems have
been shown to be important for resistance to HSV. In fact, removing them results in
heightened susceptibility (53).

An

old study on HSK indicated that

NK

removal

ameliorated HSK (54, 5 5), although this issue warrants further investigation.
Whatever the source o f IFNy, this molecule a ppears intricately involved i n antigen
processing as well as other events critical for HSK pathogenesis. These include
upregulation of the cell adhesion molecule PECAM- 1 on vascular endothelial cells, at
the limbus (56). This is a necessary step for normal PMN invasion as evidenced by
the fact that neutralization of IFNy or PECAM - 1 results in diminished PMN ingress
(56).
The importance of IFNy in facilitating cell migration is further underscored by
studies with human corneas. Stimulation of human corneal cells in vitro with IFNy,
and also IL-l and TNFa. , rapidly upregulates ICAM- 1 expression (another cell
·

adhesion molecule that participates in the adhesion and extravasation of cells) (57).
IFNy also upregulates MHC Class II expression on the antigen presenting cells
.
+
involved in the induction of the initial antigen specific CD4 T cell response in local
draining lymph nodes (5 8, 59). On the other hand, IFNy could help modulate lesion
development since it also induces angiostatic chemokines such as IP- 1 0 and MIG
14

(4 1 ). Accordingly the IL-1 2 response to HSV infection indirectly impacts on both
inflammatory and regulatory effects on HSK.
In Figure 1 (for all figures see appendix) several critical events are shown that
are set into play by HSV during the first 6-7 days post infection. Interestingly, by the
end of this often-called pre-clinical phase, the corneal tissues show little or no
damage. The epithelium is fully intact, the stroma has few if any infl ammatory cells
and c ytokine/chemokine levels have fallen significantly. The most obvious sign of
change is a neovascular bed that continues to expand slowly beyond the limbal region.
Nevertheless, in spite of the quiet appearance, notable changes begin to occur which
constitute the true immunopathological events of HSK. Accordingly, the T cell
orchestrators begin to invade via the new blood vessels and an intense inflammatory
response ensues. This becomes obvious upon ophthalmoscopic examination and is
frequently referred to as the clinical phase.

Adaptive immune response to infection in the mouse model

Migration of T cells that express appropriate homing molecules escaping from
the n ewly established b lood vessels represents a c rucial step in H SK p athogenesis.
Mice without T cells never develop typic al HSK lesions ( 60, 61 ), but do if given T
.
cell transfers (61, 62). Although debated early on, most investigators now agree that
CD4+ T cells, with the type 1 producing cytokine phenotype, are the main aggressors
in HSK ( 6 1 , 63 ). Such cells trigger the invasion of non-specific inflammatory cells,
surprisingly once again dominated by PMN, giving rise to a peak response around 1 5
days after initial infection. The inflammatory response considerably thickens the
stroma and neovascularization continues almost reaching the central cornea (see Fig
2). Severe lesions have areas of necrosis and epithelial ulcers and uveal tissues may
15

also be involved. The lesional T cells, which account for only a minority of the
inflammatory cells present, are mainly CD4+ T cells. Judging from a variety of
approaches, the principal cytokine n ecessary for t he l esion e xpression is IFNy (56,
64). However, HSK can still be induced in animals lacking this cytokine (65). In cases
where lesions do diminish in severity, the cytokine IL-10 is upregulated (66) .
Furthermore, the artificial expression of IL-l 0 or IL-4 early in the syndrome can
markedly diminish I esions (67). Such observations indicate that CD4+ Thl are the
principal aggressors but if a type 2 response can be induced, lesions will resolve.
Whether such ideas can be applied usefully to the human system warrants
investigation.
Very recently the severity of HSK lesions was shown to be modulated by a
second species of CD4+ T cells (68). These were CD4+CD25 + T regulatory cells (Treg)
found operative in autoimmune inflammatory lesions (69). Accordingly, in animals
unable to generate Treg responses, HSK lesions were more severe and animals more
susceptible to a low dose of infection (68). In addition, there is evidence that the CD8+
T cell response to HSV provides a protective function against HSK· (61, 70). The
mechanisms by which Treg or CD8+ T cells exert controlling effects on HSK
expression are not currently understood.
A central issue in HSK pathogenesis is the nature of antigens recognized by
the CD4+ T cell orchestrators and if such recognition occurs in the extra-lymphoid or
lymphoid sites (or both). This issue becomes of interest since at the time when T cells
invade the cornea, replicating virus has usually disappeared (3 5). Moreover, certainly
at the time of peak lesions (15 days), the presence of viral antigens in stromal tissues
cannot be demonstrated (35). Conceivably, viral peptides expressed by DC could still
be present in the cornea and draining lymph nodes, although usually T cell target
16

peptides tum over within 2-3 days after protein processing. Since new protein
formation appears to have ceased by 6 days p.i., it is difficult to support the logical
notion that peptides derived from viral proteins are the target antigens recognized by
the Taggressor s.
An

alternative concept is that viral specific T cells are initially responsible for

the immunopathology but subsequently the chronic phase is maintained by an. auto
reactive response (64). Here the idea is that the virus infection results in unmasking of
the some corneal auto-antigen (see Fig 3), tolerance is broken and the auto-reactive T
cells induced are responsible for orchestrating lesions. A modification o f this idea
favored by the Cantor group is that the auto-immune process is set off by some viral
peptide sharing reactivity to the unmasked corneal auto-antigen (7 1 ) Thus the initial
.

anti-viral response subsequently becomes sustained by auto-reactive Taggresor cells.
This concept of molecular mimicry has aroused much interest and discussion (64). Its
best support comes from studies on closely related inbred mice. Here it would seem
that the UL6 protein of HSV possesses molecular mimicry with an auto-peptide that
in fact represents a sequence also found on an immunoglobulin isotype (71 ). The
molecular mimicry idea is not accepted by other groups for a number of reasons
(Table 1 , appendix). Most, especially the UL6 proteins of HSV appear not to induce T
cell responses in animals following infection with HSV (72). In humans also the UL6
protein appears not to be recognized (20, 2 1 , 73).
An

alternative idea to explain how CD4+ T cells become activated is that the

inflammatory process could be initiated by viral antigen recognizing T cells, but
subsequently is maintained by cells of the effector memory phenotype that escape into
the cornea because of the highly permeable neovascular bed. Such cells in tum
become activated by inflammatory molecules initially released by viral antigen
17

reactive cells. The responding cells, release inflammatory cytokines and so the
process continues (see Fig 4). This idea is supported by the observation that abundant
non-antigen T cel�s can be demonstrated and that it is possible to develop lesions
identical to HSK in animals whose T cells are genetically incapable of recognizing
viral antigens (74, 75). Such was shown in several T cell transgenic mice on SCID or
RAG-/- backgrounds whose recognition repertoire did not include HSV antigen
recognition (74, 75). In these models, the chronic source of activating cytokines were
cells dying of HSV infection since in this instance virus persisted and spread to the
stromal site of inflammation (74, 75).
Other ideas have also been advocated to explain which agonists drive HSK,
especially in the chronic phase, but the issue remains unresolved. The candidate
agonists

include

PAMP

expressed by virus,

superantigen expression and

inflammatory reactions driven by stress proteins (76). Currently, a favored idea is that
the HSV DNA could itself be pro-inflammatory because of its high content of
bioactive CpG containing deoxynucleotide motifs (50). Such ideas await verification.

SPECIFIC AIMS AND RATIONALE

Studies with the murine model for HSK have revealed the involvement of complex
mechanisms in its pathogenesis. Several areas, both in the pre-clinical and the clinical
phase, require further elucidation. These include the molecular events that direct the
neutrophil influx and promote viral clearance. In addition, it is not clear as to how the
early pre-clinical events lead to the development of angiogenesis, which is important
in the migration of the T lymphocytes. Furthermore, events that lead to the influx of T
lymphocytes and the role of the different T lymphocyte subsets in the pathogenesis of
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HSK is not entirely understood. Studies described here have been aimed at
understanding the above mechanisms further.
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Figure 1. Critical events of the pre-clinical phase of murine HSK

HSV -1 infection of the corneal epithelium sets up a pro-inflammatory environment.
Such an environment is responsible for directing subsequent immuno-pathology
resulting in tissue damage. Shortly after infection there is a production of various
cytokines and chemokines. These serve to activate and recruit cells of the innate
immune system. Polymorphonuclear cells (PMN), mainly neutrophils, comprise a
large number of the total cellular influx at this stage and are responsible for the
clearance of virus. Pre-clinical events set the stage for (1) tissue damage by secreted
products of neutrophils and other unidentified molecules (2) Angiogenic response
(neovascularization) in the cornea brought about by the interplay between pro (+)
(VEGF, MMP) and anti (-) (IP- 10, MiG) angiogenic factors. Dashed lines represent
those steps that require further investigation.
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B

Figure 2. Typical features of an HSV-1 infected murine eye

The photograph shows a representative eye at day 1 5 post infection (A). At this stage
eyes display c haracteristic growth of blood vessels from t he c omeal l imbus (black
arrows) and corneal opacity, necrosis and epithelial ulcers (white arrow). Shown for
comparison is an uninfected eye (B).
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Figure 3. The molecular mimicry model to explain the pathogenesis of murine
HSK

The figure summarizes the autoimmune events thought to explain HSK pathogenesis
as proposed by the Cantor laboratory (Reference 7 1 ). CD4+ T cells in the susceptible
mouse strains are activated by a peptide of the HSV UL6 tegument protein. Such cells
are also reactive to peptides from corneal antigens (yet undefined), released as a result
of viral replication in the cornea, that mimic the HSV derived peptide. Corneal tissue
damage is mediated by these auto-reactive cells.

34

HSV ocular

Generation Q.f
cytotdnesl.chem4))d

infection

nglopnes"
CD4+ lnv.. ion

�--••P..

(immune and non..spedflc)

AcUvaJiqn by viral anti&eP

Bystander activation of invading CD4+ cells of memory/ effector phenotype

Figure 4. The bystander activation model to explain the pathogenesis of murine
HSK

The bystander activation model proposes that viral antigen specific activation (nonrequirement of the TCR-MHC interaction) is not a requirement for T cells to enter the
cornea (References 74, 75). Such cells are activated by the pro-inflammatory
mediators produced in the cornea after viral infection.
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Table. 1. Evidence that challenges the molecular mimicry hypothesis
Observation

Reference

1 . Failure to demonstrate an immune

Deshpande et al (2001 ). J. Virol. 15 (7):

response directed to UL6 peptide after

3077-3088

HSV ocular infection

2. Ocular infection with vaccinia virus

Deshpande et al (200 1 ). J. Virol. 15 (7):

expressing UL6 fails to induce HSK

3077-3088

3. T cells extracted from human corneas

Verjans, G. M. et a/. (1 998). J Infect Dis.

show no reactivity to HSV UL6

177 (2): 484-488
Koelle, D. M. et al. (2000). J Virol. 14
(23). 10930- 1 0938

4. T cells extracted from human corneas

Verjans, G. M. et a/. (1 998). J Infect Dis.

are not reactive to corneal antigens

1 77 (2): 484-488,

5.

Variation in clinical presentation of SK

is not due to genetic variation in the UL6

Ellison, A. R. et a/ (2003). Virology. 3 1 0
(1): 24-28

epitope
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EARLY EVENTS THAT DETERMINE
SUSCEPTIBILITY TO HSK: THE ROLE OF IL-6
IN THE INDUCTION OF ANGIOGENESIS
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Research described in this chapter is a slightly modified version of an article
published in 2004 in The Journal ofImmunology by Kaustuv Baneijee, Partha Sarathi
Biswas, Bumseok Kim, Sujin Lee and Barry T Rouse:

Banerjee, K. , Biswas, P. S., K im, B., L ee, S. and Rouse, B. T. (2004). CXCR2-/

mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6
induced neovascularization. The Journal of Immunology, 1 72: 1 237- 1 245. Copyright
2004. The American Association ofImmunologists, Inc.

In this chapter "we" and "our" refers to co-authors and me . My contributions in the
paper include ( 1 ) selection of the topic (2) data analysis and interpretation (4)
planning experiments (5) compiling and interpretation of the literature (6)
understanding how results fit with the literature (7) compilation of contributions into
one paper (8) providing structure to the paper (9) making graphs, figure and tables
(1 0) writing and editing

ABSTRA CT

Ocular infection with herpes simplex virus (HSV) results in a blinding immuno
inflammatory lesion known as Herpetic Stromal Keratitis (HSK). Early pre-clinical
events i nclude i nflammatory c ell, mainly neutrophils, infiltration o f t he stroma and
neovascularization. To further evaluate the role of neutrophils in pathogenesis, HSV
infection was c ompared in BALB/c and mice of the s arne background but lacking
CXCR2, the receptor for chemokines involved in neutrophil recruitment.
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Our results show clear differences in the outcome of ocular HSV infection in
CXCR2-/- compared to control BALB/c mice. Thus CXCR2-/- animals had minimal
PMN influx during the first 7 days post infection and this correlated with a longer
duration of virus infection in the eye compared to BALB/c mice. The CXCR2-/- mice
were also more susceptible to HSV induced lesions and developed HSK upon
exposure to a dose of HSV that was minimally pathogenic to BALB/c mice.
The basis for the greater HSK lesion susceptibility of CXCR2-/- mice was
associated with an elevated IL-6 response, which appeared in tum to induce the
angiogenic factor VEGF. Our results serve to further demonstrate the critical role of
angiogenesis in the pathogenesis of ocular lesions.

INTR ODUCTI ON

Herpetic Stromal Keratitis (HSK) is an immunopathological reaction that results from
ocular infection with herpes simplex virus (HSV) ( 1 ) . The lesion occurs naturally in
humans and is a frequent cause of blindness (2). HSK is usually studied in the mouse
and, as in humans, the pathogenesis involves immunopathology { 1 , 3). Multiple
events are involved in the pathogenesis of HSK with CD4+ T cells and neutrophils
appearing as the pivotal cellular mediators (3-7). Neutrophil infiltration into the
avascular cornea occurs promptly after HSV infection likely in response to signaling
molecules p roduced e ither b y i nfected c ells or nearby c ells s timulated by p roducts
released from infected cells ( 6, 8). The PMN influx may have several consequences.
These include anti-viral effects, release of angiogenesis factors and possibly the
unmasking of corneal autoantigens that help drive the ocular inflammatory response
(6, 9, 1 0). Currently, the identity of the major signals responsible for the PMN influx
into the HSV infected eye remain uncertain. However, several CXC chemokines that
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cause PMN chemotaxis in other systems are present soon after HSV infection ( 1 1 ),
and M IP-2 (CXCL1) w as implicated indirectly as i nvolved in H SV i nduced ocular
neutrophil influx ( 1 2, 13 ) Although in humans the main chemokine attractant for
.

PMN is IL-8, which engages the two high affinity receptors CXCR1 and CXCR2, the
mouse lacks IL-8 and only CXCR2 acts as the receptor for PMN attracting CXC
chemokines ( 1 4, 1 5). In consequence, animals lacking CXCR2 due to gene knockout
(CXCR2-/-) are expected to show defects in neutrophil chemotaxis. Such was
observed in at least 4 systems including ocular inflammatory responses induced by
infection with the parasite Onchocerca volvulus (1 6-22). Since the PMN influx
appears as a crucial event in HSK, the availability of the CXCR2-/- mice on the HSV
susceptible BALB/c background should clarify the actual role of the PMN influx in
the pathogenesis of lesions.
Our results show clear differences in the outcome of ocular HSV infection in
CXCR2-/- compared to control BALB/c mice. Thus CXCR2-/- animals had minimal
PMN influx during the first 7 days p. i. and this correlated with a longer duration of
virus infection in the eye compared to BALB/c mice. The CXCR2-/- mice were also
more susceptible to HSV induced lesions a nd developed HSK upon exposure to a
dose of HSV that was minimally pathogenic to BALB/c mice. The basis for the
greater HSK lesion susceptibility of CXCR2-/- mice was associated with an elevated
IL-6 r esponse, w hich appeared i n turn to induce the a ngiogenic factor V EGF.

0 ur

results serve to further demonstrate the critical role of angiogenesis in the
pathogenesis of ocular lesions.
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MATERIALS AND METHODS

Animals

Female BALB/c-Cmkar2tm tMwm (CXCR2-/-) [Jackson Laboratory, Bar Harbour,
Maine], BALB/c (Harlan Sprague Dawley, Indianapolis, IN), 6 to 8 week old, were
used for the studies. Mice were housed in sterile micro-isolator cages and all food,
bedding and instruments were autoclaved or disinfected. Manipulations were done
under a laminar flow hood. To prevent bacterial super-infection, mice received
prophylactic treatment of Sulfamethoxazole/Trimethoprim

(Alpharma, Baltimore,

MD) at the rate of 5ml per 200ml of drinking water. Antibiotic treatment was started 1
day before the beginning of experiments. All experimental procedures were in
complete agreement with the Association for Research in Vision and Ophthalmology
(ARVO) resolution on the use of animals in research.

Virus

HSV -1

RE

strain (obtained from the laboratory of Dr. Robert Hendricks, University

of Illinois at Chicago) was propagated and assayed on Vero cells for the measurement
of PFU by standard protocols (23).

Corneal HSV infection, clinical observation and angiogenesis measurement

Corneas of mice, deeply anesthetized by Avertin (Pittman Moore, Mondelein, IL),
were scarified with a 27-gauge needle. A 4J.ll drop containing the required dose of
virus was applied to the scarified cornea and gently massaged with the eyelids.
Animals were examined at different days post infection with a slit lamp
biomicroscope (Kowa Co., Nagoya, Japan) and the severity of clinical keratitis of
individually marked mice was recorded. Briefly, the clinical lesion score of HSK was
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described as 0, normal cornea; 1 , mild haze; 2, moderate haze, iris visible; 3, severe
haze, iris not visible; 4, severe haze and corneal ulcer; 5, corneal rupture.
Angiogenesis scoring was done as previously described (24). To quantify the degree
of neovessel formation two primary parameters were used: 1 ) the circumferential
extent of neovessels (as the angiogenic response is not uniformly circumferential in all
cases); 2) the centripetal growth of the longest vessels in each quadrant of the circle.
The longest neovessel in each quadrant was identified and graded between 0 (no
neovessel) and 4 (neovessel in the corneal center) in increments of - 0.4 mm (radius
of the cornea is

�

1 .5 mm). According to this system, a grade of 4 for a given

quadrant of the circle represents a centripetal growth of 1 . 5

mm

toward the corneal

center. The score of the four quadrants of the eye were then summated to derive the
neovessel index (range, 0 to 1 6) for each eye at a given time point.

Virus recovery and titration

Eye swabs were taken from infected corneas (four animals/group) using sterile swabs
soaked in DMEM containing 1 0 IU/ml penicillin and 1 OOJ.!g/ml streptomycin. Swabs
were p ut in sterile tubes containing DMEM a nd s tored at - 80°

C.

F or detection o f

virus, s amples were t hawed and v ortexed. Duplicate 200J.!l aliquots of d ilutions of
each sample were plated on Vero cells grown to confluence in 24 well plates at 3 7°

C

in 5% C02 for l hr 30 min. Medium was aspirated and 500J.!l of 2x DMEM containing
1 % low-melting-point agarose was added to each well. Titers were calculated as log 10
pfu/ml as per standard protocol (23).
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Corneal Intrastromal Injection assay

Corneal intrastromal injection was performed as described before (25). Under direct
stereomicroscopic observation, a nick in the epithelium and anterior stroma of mouse
cornea was made with a 1 12 -inch 30-gauge needle with a 30° bevel, in the mid
periphery. For each cytokine to be tested 8 eyes were injected. The needle was
introduced into the corneal stroma and advanced 1 .5 mm to the corneal center. Two
microliters of solution containing the required concentration of cytokine was forcibly
injected into the s troma t o s eparate the corneal lamellae and disperse the solution.
Recombinant murine IL-6 (Endotoxin level < 1 .0 EU per 1 J..Lg of protein) and VEGF
(Endotoxin level < 0. 1 ng per 1 J..Lg of protein) were purchased from R & D systems.
PBS was used as a control. For VEGF neutralization experiments, anti-mVEGF
neutralizing a ntibody (2 J..Lg) ( R & D S ystems) was m ixed w ith 200ng o f IL-6 a nd
injected intrastromally. The length of the neovessels generated from the limbal vessel
ring toward the center of the cornea was measured on days 2, 4 and 7. The length and
width of the neovessels was calculated in clock hours (each clock hour equal to 30° at
the circumference). The angiogenic area was calculated according to the formula
2
A= {Clock hours x 0.4 x vessel length(mm) x n} /2 and expressed as mm •

Quantitative RT-PCR

Total RNA from 4 corneas/time point was extracted by using RNeasy protect mini kit
(Qiagen, CA). Briefly tissues were lysed in RLT buffer and RNA was purified
according to manufacturer's i nstructions. RNase free DNase s et ( Qiagen, CA) w as
used to remove any contaminating genomic DNA. To generate eDNA, 1 J..Lg total RNA
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was reverse transcribed by MMLV reverse transcriptase (Promega, WI). All eDNA
samples were aliquoted and stored at -20° C till further use.
Real time PCR was performed using a DNA Engine Opticon (MJ research
Inc., MA). Quantitect SYBR green PCR kit (Qiagen, CA) was used according to
manufacturer's protocol. PCR amplification of house keeping gene, murine GAPDH,
was done for each sample as a control for sample loading and normalization between
samples. A standard curve was constructed with PCR-II Topo cloning vector
(Invitrogen, CA) with the inserted fragment amplified by the SYBR green I system.
PCR r eaction w as carried o ut for three d ilutions o f e ach sample ( in d uplicate). T o
confirm amplification specificity, the PCR products were subjected to a melting curve
analysis and subsequent agarose gel electrophoresis. Copy number for the target gene
was then normalized to 1 06 copies of GAPDH control and data represented as copy
numbers

/cornea.

The primers

used were murine

IL-6

primer,

Forward

TTCCATCCAGTTGCCTTCTT and Reverse CAGAATTGCCATTGCACAAC and
murine GAPDH primer, Forward CATCCTGCACCACCAACTGCTTAG and
Reverse GCCTGCTTCACCACCTTCTTGATG

Histopathology, Immunohistochemistry and Immunoflourescence

For histopathological analysis eyes were extirpated and fixed in 1 0% buffered neutral
formalin and embedded in paraffin. Sections ( 5 J.lm thick) were cut, deparaffinized and
stained with hematoxylin and eosin. PMN were identified based on their morphology
under 1000x magnification. Cell counts were done on three eyes/group, two
sections/eye scanning the limbus, paracentral and central areas of the cornea. The
number of PMN per section was averaged and the SD between the three eyes was
computed.
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For immunohistochemistry and immunofluorescence analysis, eyes were
enucleated at the i ndicated time points a nd s nap frozen i n O CT c ompound ( Miles,
Elkart, IN). Six micron thick sections were cut, air dried and fixed in
acetone:methanol ( 1 : 1 ) at -20° C for 1 0 min. Endogenous peroxidase activity was
blocked using a 50 % alcohol solution containing 0.3 % hydrogen peroxide for 1 5
minutes and sections were blocked with 3 % BSA-PBS. Antibody dilutions were
made in 1 % BSA-PBS. For detection of neutrophils, biotinylated anti-Grl mAb
(Clone RB6-8C5, Pharmingen) was diluted 1 / 1 00 and incubated overnight at 4° C.
For detection of HSV antigens, sections were treated with rabbit anti-HSV anti-serum
(1 Omin) (Dako, Carpentaria, C A) followed by biotinylated anti-rabbit Ab ( 20 m in)
(Biogenex, San Ramon, CA). Sections were then treated with HRP- conjugated
streptavidin for 45 min (1 : 1 000 dilution, Jackson Immunoresearch Laboratories)
followed by 3, 3 '

-

diaminobenzidine substrate (Biogenex, San Ramon, CA) and

counterstained with hematoxylin (Richard Allen Scientific, Kalamazoo, MI).
Irrelevant biotinylated rat antibodies and normal rabbit serum was used as negative
controls. For immunoflourescence counting of neutrophils acetone:methanol fixed
sections were blocked with 5% BSA-PBS-0.05% Tween 20 containing 1/200 dilution
of Fe block (Clone 2.4G2, Pharmingen) for 2 hrs followed by overnight incubation
with 1/500 dilution of FITC anti-Grl (Pharmingen) in 1 % BSA-PBS-0.05% Tween
20.

Slides were mounted with Vecta-Shield reagent (Vector Laboratories,

Burlingame, CA). Gr-1 +ve cells were counted from two sections/eye and three
eyes/time point using a fluorescence microscope. For this purpose, the corneal section
was divided into the limbal regions (roughly the part of the cornea marked by area of
origin of the iris) and the central region (paracentral and central).
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Cytokine ELISA of corneal lysates

For preparation of corneal lysates, 5-6 corneas/time point were pooled and minced.
All procedures were done on an ice bath. Minced pieces were collected in 1 ml of
DMEM without FCS and homogenized using a tissue homogenizer (PRO Scientific
Inc., Monroe, Conn) four times, 1 5 seconds each with a gap of 1 min between
homogenization to allow the sample to cool on ice. The lysate was then clarified by
centrifugation at 14,000 rpm for 5 min at 4° C. The supernatant was collected and
used immediately or stored at -80° C till further use. Lysates were assayed using a
standard sandwich ELISA protocol. Anti-IL-6 capture and biotinylated detection
antibodies were from Pharmingen (Clone MP5-20F3) and standard rmiL-6 was from
R

&

D systems Inc, Minneapolis, MN. Anti-MIP2 and anti-VEGF capture and

biotinylated detection antibodies and recombinant standards for MIP-2 and VEGF
were from R

&

D systems. The color reaction was developed using ABTS (Sigma)

and measured with an ELISA reader (Spectramax 340, Molecular Devices) at 405nm.
The detection limit was 2 pg/ml. Quantification was performed with Spectramax
ELISA reader software version 1 .2.

Statistics

Statistical analysis was performed utilizing standard student's t test.

RESUL TS
Neutrophil influx following HSV infection

A prompt consequence of HSV infection of the cornea in BALB/c mice is PMN
influx (6). This, as shown in Fig. 1 (all figures located in appendix), is evident as early
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as 1 2hr p.i., peaks around 2 days p.i. and subsides greatly by day 5 . This is the
preclinical phase of HSK. Clinically evident lesions start around day 8 p.i. and are at
their peak at 1 5-2 1 days p.i. (3). The pattern of PMN influx in CXCR2-I- mice
differed from that in BALBIc animals both in terms of the level of response and
location of the cells in the corneal stroma (Fig 2A). Thus, whereas in BALBic mice
PMN were abundantly present in the paracentral and central cornea, in CXCR2-1mice PMN were mainly confined to the limbal area (the vascular part of the cornea)
(Fig 2A). In terms of total PMN numbers in the cornea at the 2 day peak, the response
of CXCR2-I- mice was around 30% that of BALBic mice (Fig 1 ). However, PMN
numbers in the I imbal areas were a pproximately equal (Fig 2A). Thus as n oted in
some other systems, PMN appeared not to migrate beyond the vascular release site
( 1 6, 26). In addition, as revealed by H & E staining, the total number of inflammatory
cells infiltrating the corneas of CXCR2-1- mice, at day 2 p.i., was lower compared to
BALBic mice (Fig 2B and Table 1 , all tables located in appendix). Neutrophils
comprise the majority of cells infiltrating the corneas of BALBic mice at this time
point, being almost 2 times that of monocytes (Table 1 ). In contrast, neutrophil counts
were far lower in CXCR2-I- corneas and interestingly a majority of cells in such
corneas were monocytes (Table 1 ). However there was no significant difference in the
numbers of infi1trating monocytes in corneas of CXCR2-/- mice compared to BALB/c
mice (Table 1 ). Neutrophil counts in BALBic and CXCR2-I- mice were also
compared at day 1 5 during the clinical phase of HSK. Surprisingly, PMN were well
represented in the central cornea in CXCR2-1- mice, and acco�nted for approximately
the s arne percentage o f the i nflamm�tory c ells a s w as the c ase with B ALBic m ice
(Table 1 ).
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Viral clearance in CXCR2-/- and BALB/c mice

Previous reports had noted that PMN depletion in BALB/c mice resulted in prolonged
viral presence and animals often succumbed to HSV induced encephalitis {6, 9). Thus
it was anticipated that viral clearance might be impaired in CXCR2-/- mice because of
the diminished PMN response. To measure such an effect, groups of CXCR2-/- and
BALB/c mice were infected at either a high (5x 10 5 pfu) or low (5x104 pfu} dose of
virus, and eye swabs were collected daily for viral titration While virus was detectable
in swabs from CXCR2-/- mice, until at least day 7, even after infection with the low
dose, BALB/c mice had cleared virus by this time point {Table 2). Conceivably, in the
corneal tissues themselves virus could have been present several days beyond day 7.
Thus upon analysis o f frozen sections for the presence of viral a ntigens on day 7 ,
abundant antigen was present in CXCR2-/- eyes (Fig 3) but antigen was absent by day
6 in BALB/c mice [data not shown, (6)]. Even more of interest, whereas in BALB/c
mice viral antigen was evident only in the epithelium [data not shown and (6}], in
CXCR2-/- mice antigen found after day 5 p.i., including the day 7 samples, was
·
present in the stroma itself (Fig 3). Such a pattern of antigen expression was noted
previously in B cell K/0 (27) and transgenic SCID/RAG-/- mice (28, 29).
Taken together, our results indicate that CXCR2-/- mice clear virus less
effectively than wild type mice and the virus spreads to a tissue location that is not
found in the wild type mice.

Stromal Keratitis in CXCR2-/- and BALB/c mice

Groups of CXCR2-/- and BALB/c mice of the same age (6-8 weeks) were infected
ocularly with either 5x105 or 5x104 pfu HSV-1

RE

and animals were followed at

intervals over a 20-day observation period to measure a) the extent of corneal
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angiogenesis and b) the clinical severity of HSK. At the high dose level of infection,
the pattern of events in the two strains was similar (Fig 4 and 5). Thus cumulative
results from 2 separate experiments revealed that 1 7 of 20 eyes from CXCR2-/- mice
develop significant lesions compared to 1 9 of 20 eyes from infected BALBIc mice.
The average severity score and time of peak lesions did not differ significantly
between the two groups (Fig 4 A, C, D). In addition, the extent of corneal
neovascularization in both groups of mice was of similar magnitude (Fig 5 A and B).
Representative eyes from CXCR2-/- and BALB/c mice showing equal clinical
severity (score of 4) were examined histologically following H & E staining. Such
eyes showed similar inflammatory changes and influx of a large number of
inflammatory cells (Fig 6A), which included Gr-1 +ve cells, as revealed by
immunohistochemical analysis (Fig 6B).
Whereas a comparable outcome of events occurred after high dose infection,
dramatic differences in the responsiveness of CXCR2-/- and BALB/c mice was
observed upon infection with the lower dose of virus. Accordingly only 3 of 20 eyes
in BALB/c mice developed notable clinical lesions (score of 3 or higher),
significantly m ore ( 1 2 of 20 e yes) CXCR2-/- m ice responded w ith positive l esions
(Fig 4 C, D). In consequence, the average severity score at the peak time point was
significantly higher in CXCR2-/- mice (Fig 4 B). Eyes of CXCR2-/- mice developing
disease with the lower dose of infection were histologically similar to that seen with
eyes from the higher dose infected mice (Fig 6A) with large number of Gr-1 +ve cells
(Fig 6B).
As with lesion incidence and severity, significant differences were apparent in
the average extent of angiogenesis in �XCR2-/- and BALB/c mice following
infection with low dose virus (Fig 5). By day 1 0 p.i., extensive angiogenesis was
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evident in the CXCR2-/- group (Fig SA) and at day 20 p.i., 1 2 of 20 eyes from
CXCR2-/- mice had developed an angiogenesis score greater than 1 0 (Fig 5B). In
marked contrast, only 4 of the 20 eyes of BALB/c mice developed equivalent scores
(Fig 5B). When the overall angiogenesis was compared in the groups of CXCR2-/
and BALB/c mice the average angiogenesis score was 3 times (day 20 p.i.) that
observed in BALB/c mice (Fig 5 A and B). Thus in spite of a diminished neutrophil
migration response to HSV infection in CXCR2-/- mice, angiogenesis appeared to be
enhanced.

Cytokines and chemokine production in infected corneas

So far o ur experiments indicate that CXCR2-/- m ice show greater susceptibility t o
HSV infection than BALB/c animals and that this response reflects as more
neovascularization i n CXCR2-/- mice. P revious reports h ad d emonstrated that I L-6
was one of the few cytokines produced by susceptible corneal cells following HSV
infection (30). Moreover, IL-6 was implicated as a critically important molecule
during pathogenesis of corneal disease following HSV -1 infection (3 1 ). Furthermore
CXCR2-/- m ice express h igh c irculating 1 evels of IL-6 ( 1 5). F inally IL-6 c ould be
involved in angiogenesis since it was shown to induce the potent angiogenesis factor
VEGF (32, 33). To determine if levels of corneal IL-6 were elevated in CXCR2-/
mice compared to BALB/c controls, groups of mice were infected with a low dose of
HSV and sacrificed at intervals during the first week p.i. Corneal tissues were
processed both to measure IL-6 mRNA and protein levels. As is evident in Fig 7, both
mRNA and protein levels for IL-6 were significantly higher in the CXCR2-/- mice.
The greatest differences were noted between day 2 and 5 where protein levels were
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upto 50 fold and mRNA levels 1 00 fold increased in CXCR2-/- compared to BALB/c
mtce.
Since the IL-6 cytokine may influence expression of the chemokine MIP-2
and the angiokine VEGF (3 1 , 32), levels of these proteins were also measured by
ELISA. Both molecules were elevated in CXCR2-/- samples taken from mice infected
with low dose of virus (Fig 8 B and D). In addition, groups of mice were also infected
with the high dose so that similar numbers of animals would eventually develop
lesions. Protein levels of both VEGF and MIP-2 were higher in CXCR2-/- mice
compared to BALB/c mice at day 5 and 7 post infection (Fig 8 A and C). Thus our
data are consistent with the hypothesis that CXCR2-/- mice develop heightened
angiogenesis, and susceptibility to HSK, because their elevated IL-6 response caused
production of the angiokine VEGF. Moreover even though CXCR2-/- mice have
elevated MIP-2 levels the PMN response to it is minimal over that seen in BALB/c
mice.

Verification that IL-6 induces VEGF production in mouse corneas in vivo

To avoid the complication of virus infection and to determine the potential for IL-6 to
induce VEGF production in the eye, experiments were done in BALB/c mice in which
the IL-6 was injected directly into the corneal stroma. Measurements were then made
of V EGF p roduction ( in c omeal extracts) a nd levels of a ngiogenesis. C omparisons
were made with recombinant VEGF 164 protein injected into the stroma as well as with
negative PBS control injections.
The results show that IL-6 injection led to both angiogenesis and VEGF
production (Fig 9 and 1 0). With regard to angiogenesis, IL-6 induced significant
responses evident at 48hr but these had declined �y day 4 post injection (Fig 9A). The
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response to VEGF positive control protein was greater than that of IL-6 and in this
case the peak response was evident at 4 days post injection (Fig 9A). In addition, the
quality of the IL-6 and VEGF responses appeared to differ. Thus the blood vessels
evident after IL-6 injection were finer and less dense that those induced by VEGF
(Fig 9B). This may mean that additional factors are involved in IL-6 induced
angiogenesis. However the results shown in Fig 9 and 10, do indicate that VEGF was
part of the IL-6 induced angiogenic response. Thus the angiogenesis induced by the
injection of IL-6 could be blocked by administration of anti-murine VEGF (Fig 9). In
addition corneal lysates at 48hr post IL-6 injection contained significant levels of
VEGF as measured by ELISA (Fig 1 0). In contrast VEGF was not present in PBS
injected corneas.

IL-6 induces VEGF production in vitro

To c onfirm that I L-6 directly i nduces cells t o p roduce V EGF, t he J774A. l murine
macrophage cell line was used which can be induced to express VEGF upon infection
with virus (Zheng and Rouse, unpublished results). Such cells were reacted for 1 2 or
24 hr with different concentrations of IL-6, LPS or unstimulated. VEGF production
was measured in the . cell supernates by ELISA, and the cells themselves were
harvested to quantify VEGF mRNA by RT-PCR. The results shown in Fig. 1 1
demonstrate that IL-6 induced VEGF production, measured by both assays.

DISCUSSION

This report deals with stromal keratitis, a blinding immunoinflammatory lesion of the
corneal stroma that results from HSV infection of the eye. It is well established that
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HSK lesions

in humans as well as animal model

systems are largely

immunopathological and orchestrated by T cells, principally the CD4+ subset (3-5, 7).
However, in the murine model the most prominent initial cellular event in HSV
infected eye is an abundant influx of mainly PMN into the corneal stroma. Several
functions have been attributed to such infiltrates, but their precise role as well as the
identity of molecules responsible for the influx remain poorly defined. In the present
report, we have compared the.outcome of oc:ular infection in wild type BALB/c mice
with mice of the same background but lacking the expression of the chemokine
receptor CXCR2. Thus, as shown in other systems, such mice exhibit defective PMN
migration to inflammatory sites ( 1 5, 1 7, 1 9, 2 1 , 22). Our results show that CXCR2-/
mice generated minimal PMN influx into the paracentral and central corneal stroma
following HSV infection. The knockout mice were also less able to clear HSV from
the eye and more susceptible to HSK development than were BALB/c mice. The
increased susceptibility of CXCR2-/- mice appeared to be the consequence of a
heightened IL-6 response that in
neovascularization. Thus these

data

tum

stimulated VEGF induced corneal

serve to further emphasize the importance of

angiogenesis in the pathogenesis of HSK.
A prominent early event after virus infection of the cornea is influx into the
avascular stroma of inflammatory cells, primarily PMN (6).

This influx occurs

promptly after infection and likely serves several functions. These include antiviral
effects (6, 9) and an involvement in neovascularization ( 1 0). The signals responsible
for the PMN influx are likely multiple and non-viral derived.

Several CXC

chemokines are upregulated following HSV infection (1 1 , 30) and one of them, MIP2, was indicated t o b e a major m ediator i n b oth HSV and other p athogen induced
PMN corneal infiltrates ( 1 2, . 1 3 , 34, 3 5).
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These reports await confirmation.

Moreover, with HSV, the source of MIP-2 remains undefined and would not seem to
be the infected cells themselves (our unpublished results). Since in the mouse a single
receptor, CXCR2, is used by all CXC PMN-attracting ligands (14, 1 5), the absence of
this molecule should result in changes in PMN recruitment and help reveal the role of
such cells in pathogenesis.

Our results clearly showed that only minimal PMN

invasion occurred into the stroma following HSV infection of CXCR2-/- mice. The
effects were most evident in the avascular paracentral and central corneal locations.
Thus at the limbal region, which is close to blood vessels, PMN were abundant in
both CXCR2-/- and BALB/c mice indicating that vascular escape still o ccurred in
CXCR2-/- mice but PMN migration was compromised.
A major consequence of the diminished PMN influx was that CXCR2-/- mice
were more susceptible to infection. Thus virus persisted for longer periods in the eye.
In addition, the virus gained access to the stromal tissue site, a situation noted
previously only in immuno-compromised animals (27-29) . This circumstance likely
reflects movement to the stroma via zosteriform spread from infected nerve ganglia,
an event normally contained by the immune system (36, 3 7). How PMN contribute to
such immune control remains unknown but IFNy and TNF a. have been suggested to
be participants in the antiviral effect (3 8, 39).
Previous reports had indicated that PMN contributes to corneal angiogenesis
following HSV infection ( 1 0). Thus we expected to observe that this process might
be diminished in CXCR2 mice that have minimal PMN responses to HSV. In fact the
contrary result was observed with the extent of angiogenesis being enhanced in
CXCR2-/- mice compared to BALB/c mice. This was particularly noticeable when
low virus doses were used for infection. The heightened angiogenesis noted in
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CXCR2-/- mice correlated with the increased severity of HSK lesions, supporting the
concept that angiogenesis plays a crucial role in the pathogenesis of such lesions (40).
Curiously, in the clinical phase, once extensive angiogenesis had occurred, the PMN
representation in the central cornea of CXCR2-/- mice was comparable to that of
BALB/c animals. However, t�e PMN in CXCR2-/- vs. the BALB/c mice did appear
to occupy different locations in the two strains. Thus many of the PMN counted were
seen to be within blood vessels in the CXCR2-/- corneas, while in the BALB/c mice
these were mostly extravascular. In addition, the fact that PMN numbers were
approximately equal in both strains, late in disease, might reflect the operation of
additional PMN chemotactic factors. MIP- 1 a. represents a possible candidate based on
previous reports (4 1 ) This issue is under investigation.
.

An

explanation for the greater neovascular response to HSV of CXCR2-/

mice could I ie with t heir d ifferential IL-6 p roduction. Thus for u nknown r easons,
CXCR2-/- mice have elevated serum IL-6 levels compared to BALB/c mice ( 1 5). In
our studies too, we observed that levels of both mRNA and IL-6 protein levels in the
cornea of HSV infected CXCR2-/- mice were higher (up to 1 00 fold) than those in
control i nfected m ice. T he cellular s ource of the increased IL-6 response was not
defined but it could include virus-infected cells themselves. Thus IL-6 is known to be
produced by virus infected cells whereas most host proteins are rapidly switched off
by HSV (4 1 ) It is known that HSV infection does result in the up-regulation of
.

several host proteins but these m ainly d erive from i nfected c ells. Examples o f t his
phenomenon include IL- 12 and VEGF (8, 24) Our results indicate that IL-6 was
.

involved in anagiogenesis as a consequence of i nducing VEGF. In support of this
notion, VEGF protein levels were increased in the corneas of HSV infected CXCR2-/
mice over those comparably infected BALB/c animals. In addition, confirming
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previous reports (32, 33), we showed with J774 A. l cells exposed to IL-6 in vitro
caused them to express VEGF. Finally, we demonstrated that injection of IL-6 into
the corneal stroma of mice resulted in angiogenesis, an effect inhibited by anti-VEGF
administration.
Taken together, our results support the hypothesis that PMN play an important
role in HSV induced ocular lesions.

Their normal function is required to help

minimize the development of HSV induced lesions. This is in part the consequence of
PMN mediated antiviral effects.

Another effect may involve the regulation of

angiogenesis. This idea was supported by the observation that when PMN influxes
into the cornea were minimal because of faulty responses to chemokines,
angiogenesis was i ncreased and a nimals d eveloped m ore severe HSK lesions. T his
regulation is indirectly linked to antiviral effects and the pro-inflammatory
environment. An important component of this environment, defined in the current
study, is the cytokine IL-6. Apart from it's role in the induction of angiogenesis, the
recent observations that IL-6 inhibits regulatory T cells (42), may provide an
additional explanation for the heightened HSK seen in CXCR2-/- mice. This issue is
currently under investigation. It will be important to define if the scenario that
emerges from studies of the CXCR2-/- mouse can be confirmed in other models.
Studies on double knockout CXCR2 and IL-6 mice would be of particular interest.
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Figure 1. Kinetics of PMN migration into CXCR2-/- corneas after HSV-1
infection.

5
CXCR2-/- and BALB/c mice were infected with 5x1 0 pfu/eye with HSV- 1

RE.

Ocular sections from eyes of mice sacrificed at the indicated time points were stained
with Gr- 1 FITC and PMN were counted under 400x magnification using a
fluorescence microscope (2 sections/eye and 3 eyes/time point). Results are expressed
as mean counts for each time point ± SD. *p<O. 05
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Figure 2. A majority of PMN in the HSV infected CXCR2-/- corneas are found at
the limbus

A.

Mice were infected with 5x1 05 pfu/eye with HSV -1 RE. Ocular sections were

made from e yes of m ice s acrificed at i ndicated time points a nd s tained with F lTC
labeled Gr-1 and PMN were counted under 400x magnification using a fluorescence
microscope (2 sections/eye and 3 eyes/time point). Cells were counted in the limbal
region (roughly the area marked by the point of origin of the iris) and the paracentral
and central corneas. Results are expressed as mean counts for each region for each
time point.
B.

Mice were sacrificed at day 2 p.i. and eyes processed for paraffin embedding

and H & E staining. Photographs show reduced number of inflammatory cells in the
paracentral area of the cornea of a CXCR2-/- mouse compared to BALB/c mouse.
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Figure 3. Immunohistochemistry for viral antigens in corneas of CXCR2-/- mice

A & B. Viral antigens (arrows) are detectable in corneal stroma of CXCR2-/- mice
infected with high; 5x 1 05 pfu (A) and low; 5x 1 04 pfu (B) HSV- 1 RE at day 7 p.i.
DAB was used as substrate and sections were counterstained with haematoxylin.
Original magnification x200.
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Figure 4. Enhanced HSK severity in CXCR2-/- mice

A & B. Results show the kinetics of the development of HSK lesions in CXCR2-/4
and BALB/c mice infected with 5x1 05 pfu (A) and 5x1 0 pfu (B) HSV- 1 RE.
4
C & D. Severity of HSK lesions in mice infected with 5x 1 05 pfu and 5x1 0 pfu HSV1 RE at day 20 p.i. Each dot represents the HSK score from one eye. Horizontal bars
and figures show the mean for the groups. Data is compiled from two separate
experiments consisting of 5 animals in each group.
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Figure 5. Enhanced angiogenic response in CXCR2-/- mice infected with HSV-1
A.

5
Kinetics of angiogenesis in mice infected with 5x l 0 pfu and 5xl 04 pfu HSV-

1

Angiogenesis scores were recorded as described in the text at indicated time

RE.

points. Data i s c om piled from t wo s eparate experiments consisting o f 5 animals i n
each group and i s expressed as mean ± SD. *p<O. 05
B.

Angiogenesis scores for individual eyes of CXCR2-/- and BALB/c mice

infected with 5x 1 05 and 5x 104 pfu HSV -1

RE

at day 20 p.i. Horizontal bars and

figu�es show the mean for the groups. Data is compiled from two separate
experiments consisting of 5 animals in each group.
At day 1 5 p. i. extensive growth of blood vessels can be seen in CXCR2-/- mouse
5
corneas infected with 5xl0 pfu and 5xl 04 pfu HSV- 1

RE.

BALB/c mice show minor

angiogenic sprouts near the limbal ring with the lower dose (arrows)
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5x104

BALBic

CXCR2-/-

Figure

6.

BALB/c

Ocular lesions seen in

CXCR2-/-

CXCR2-/- animals show histological

characteristics similar to that seen in BALB/c

A.

Mice were terminated on day 20 p.i. and eyes processed for paraffin

embedding. Haematoxylin & Eosin staining was carried out on 6J.1 sections.
Magnification x200.
B. Large number of neutrophils can be detected in eyes from CXCR2-/- mice (day 20
p.i.) showing HSK with both 5x1 0 5 pfu and 5x1 04 pfu virus doses (arrows). DAB was
used as the substrate and sections were counterstained with Haematoxylin. Original
magnification x200.
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Figure 7. Higher expression of iL-6 mRNA and increased IL-6 protein levels in
HSV-1 RE infected corneas of CXCR2-/- mice.

A.

At indicated time points 4 corneas/group were processed for the extraction of

cellular mRNA. Real time PCR analysis was conducted to detect IL-6 mRNA
expression in corneas of mice infected with 5x1 04 pfu of HSV-1 (see materials and
methods). Results are shown as mean ± SD of two separate experiments. *
Statistically significant difference (p<0. 05) was noted in the expression of IL-6
mRNA between CXCR2-/- and wild type BALB/c mice.

a

Copy number of the target

gene was normalized to 106 copies of GAPDH.
B.

Levels of IL-6 protein was estimated from supernatants of corneal lysates of

mice infected with 5xl 05 pfu HSV-1 RE by an antibody capture ELISA as outlined in
materials and methods. Results are expressed as mean ± SD of two separate
experiments ( 6 corneas/time point). *p<O. 05
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Figure 8. VEGF and MIP-2 synthesis in corneas of CXCR2-/- mice

Levels of VEGF and MIP-2 were estimated from supernatants of corneal lysates of
4
mice infected with 5x1 05 pfu (A, C) and 5 x 1 0 pfu (B, D) HSV- 1 RE by an antibody
capture ELISA as outlined in materials and methods. Results are expressed as mean ±
SD of two separate experiments (6 corneas/time point). *p<O. 05
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Figure 9. IL-6 induces angiogenesis in a corneal intrastromal injection assay

A. Different concentrations of recombinant murine IL-6 was injected intrastromally
into BALB/c corneas (n=8) and angiogenesis scoring was carried out on days 2, 4 and
7 after injection. VEGF was used as a positive and PBS as a negative control. For
neutralization experiments a mix of 200ng IL-6 and 2ug anti-mVEGF were injected in
a 2Jll volume. Results expressed as mean ± SD. * Significant difference (p<0. 05)
compared to PBS treatment. ** Significant difference (p<O. 05) compared to
administration with anti-VEGF neutralizing antibody
B. Representative photographs of eyes at day 2 injected with 200ng of IL-6 showing
finer and less dense blood vessel development than that seen with the same dose of
VEGF (arrows). Eyes that received IL-6 mixed with VEGF neutralizing antibody or
PBS show negligible blood vessel development at this time point.
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Figure 10. IL-6 induces VEGF and MIP-2 production in the cornea

Corneas of BALB/c mice were injected intrastromally with 200ng of recombinant
murine IL-6. Corneas were excised from mice 48hr after injection and processed for
detection of MIP-2 and VEGF from lysates (see materials and methods). Results are
expressed as mean ± SD for two separate experiments involving 5 corneas. * Below
detection limit
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Figure 1 1 . IL-6 induces VEGF production in J774A.1 cells

J774A. l cells were incubated for 1 2-24 hrs with recombinant IL-6 and LPS.
Supernatants were used in a sandwich ELISA to detect secreted VEGF (A) and total
RNA (from cell pellet) was used to detect VEGF mRNA expression by PCR (B).
GAPDH served as a standard. In other experiments J774A. l cells were treated with
200ng of IL-6 and VEGF production was detected by immuno-cytochemistry using
biotinylated anti-VEGF MAb (R & D systems) and Streptavidin-Alexa Fluor 546
after 24 hrs of incubation (C). Images were captured using a Leica SP2 laser scanning
confocal microscope.
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Table 1 . Numbers of cornea infiltrating inflammatory cells are similar between
CXCR2-/- and BALB/c mice during the clinical phase.
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A

Eyes infected with 5 x 1 05 pfu HSV -1 were enucleated and processed for paraffin

embedding and H & E staining, on the day 2 and day 1 5 (HSK score of 3) p. i. A
differential count was carried out under 1 OOOx magnification based on cellular
morphology. Two sections per eye were assayed and a total of three eyes were
studied. Results are shown as Mean ± SD for the six sections.
B

Figures in parentheses denote the percentage of each cell type of the total number

counted.
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Table 2. Viral titration shows a defect in viral clearance in CXCR2-/- mice.

Virus titer 0ogt0 pfu)1

Days p.i.

1
3

5
7
10

A

5xt0' pfu

5xl04 pfu

CXCR2-/-

BALB/c

CXCR2-/-

BALB/c

5.3 ± 0.2
2.8 ± 0.8
3 . 1 ± 0.6
2.7 ± 0.7
UD

5.5 ± 0.3
3 ± 0.1
2.9 ± 0.5
UD
UD

5 .7 ± 0.2
3 .3 ± 0.5
3.3 ± 0.4
3 .7 ± 0.2
UD

5.9 ± 0. 1
2.9 ± 0.6
2.9 ± 0.8
UD8
UD

Mice were infected with 5x 10 5 pfu and 5x 1 04 pfu of HSV- 1 RE. Virus titer was

estimated by standard plaque assay from swabs taken from infected corneas of mice
(n=4) at the indicated time points.
a

UD,

Undetected, i.e. below the sensitivity of the assay ( <1 0 pfu/ml)
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PART/II

CDS+ T CELL TRANSGENIC
MOUSE MODELS FOR HSK
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Research described in this chapter is a slightly modified verston of an article
published in 2002 by Kaustuv Banerjee, Shilpa Deshpande, Mei Zheng, Udayasankar
Kumaraguru, Stephen P. Schoenberger and Barry T Rouse:

Banerjee, K. , Deshpande, S., Zheng, M., Kumaraguru, U., Schoenberger, S. P. and

Rouse, B . T. (2002). Herpetic Stromal Keratitis in the absence of viral antigen
recognition. Cellular Immunology, 2 1 9: 108-1 1 8

Reprinted with from Cellular Immunology, 2 1 9, Banerjee, K., Desphande, S., Zheng,
M., Kumaraguru, U., Schoenberger, S. P. and Rouse, B. T. 1 08-1 1 8., 2002, with
permission from Elsevier.

In this chapter "we" and "our" refers to co-authors and me. My contributions in the
paper include ( 1 ) selection of the topic (2) data analysis and interpretation (4)
planning experiments (5) compiling and interpretation of the literature (6)
understanding how results fit with the literature (7) compilation of contributions into
one paper (8) providing structure to the paper (9) making graphs, figure and tables
( 1 0) writing and editing.

ABSTRACT

Herpetic Stromal Keratitis (HSK}, resulting from ocular infection with Herpes
Simplex Virus (HSV), is thought to represent a T cell mediated immunopathologic
lesion. Antigens recognized by the inflammatory T cells remain unresolved and nonTCR mediated activation of T cells (bystander activation) is considered as also
81

involved. This report documents further evidence for the bystander activation
mechanisms using two CD8+ T c ell t ransgenic R AG-/- mouse strains. A ccordingly
HSK occurred in P 1 4 RAG-/- and OT-1 RAG-/- mice. In none of the models could
HSV specific T cell reactivity be demonstrated and animals were unprotected from
lesion development by immunization prior to HSV ocular infection. The results
support the role of bystander activation as a mechanism of T cell mediated
immunopathology and show that CD8+ T cells can participate in HSK lesion
development.

INTR ODUCTI ON

Viruses are incriminated but difficult to convict as causes of autoimmune disease( I ).
Lesions have been advocated to result from molecular mimicry between viral encoded
antigens and host autoantigens involved in autoimmunity{ ! , 2). Such a scenario
receives strong support in a model where ocular infection with herpes simplex virus
(HSV) results in a progressive CD4+ T cell mediated immunoinflammatory reaction in
the cornea termed herpetic stromal keratitis (HSK)(3). In situations where molecular
mimicry operates, the cross-reacting antigen involved is expected to be a notable
immunogen eliciting both a viral and host reactive immune response. Molecular
mimicry is considered an explanation for HSK lesions with a peptide derived from the
UL6 protein of HSV as the apparent cross-reacting antigen (4). This provocative idea
awaits confirmation and has in fact been disputed (5, 6). Moreover, in fact it has also
been observed that HSK can be induced by virus infection in situations where CD4+
T cells fail to recognize any viral antigens including candidate cross reacting
molecular mimics (7-9). The pathogenesis in such a model was assumed to involve a
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bystander activation mechanism with the virus inducing an inflammatory environment
in the cornea that serves to activate ingressing CD4+ T cells to organize a progressive
inflammatory reaction. The T cells were assumed to be activated by non-TeR
mediated events(7 -9). Bystander activation occurs in DO 1 1 . 1 0 mice backcrossed to
RAG-/- or seiD, in which the great majority (>95%) of their T cells reacted with the
OVA323-339 peptide(7-9). Although cross reactivity between the peptides and HSV
could not be demonstrated and a search of the gene bank revealed no detectable
homology, given the fact that T cells may show considerable redundancy in epitope
recognition(l O), the observation of bystander activation in the 001 1 . 1 0 SeiD/RAG-/
might in fact represent undemonstrable cross reactivity.
In the present report, we have studied the pathogenesis of HSK in two ens +
TeR transgenic mice strains backcrossed to RAG-/- that expressed almost
monoclonal T cell reactivity. One mouse strain possessed ens+ T cells, the majority
of which recognized the GP3341 peptide of lymphocytic choriomeningitis virus
(LeMV) P 1 4 protein and the other possessed transgenic ens + T cells that recognized
the OVA257 •264 peptide of OVA. In both these TeR Tg RAG-/- mouse strains animals
developed HSK following ocular HSV infection and none developed detectable T cell
responses to HSV after either infection or immunization. These results further indicate
that the ocular immunopathology resulting from HSV infection likely proceeds via a
bystander activation mechanism of T cell activation and that ens + T cells can
participate in such reactions.

S3

MATERIALS AND METHODS

Mice

C57BU6 x C57BU10SgSnAi-[Tg]TCR LCMV P 1 4-[KO]rag2 (P 1 4 RAG-/-) mice
were obtained from the National Institute of Allergy and Infectious Disease (NIAID)
contract facility at Taconic Farms, Inc. (Germantown, N.Y.). OT- 1 RAG-/- mice
produced in the laboratory of Dr. Stephen Schoenberger (La Jolla Institute for Allergy
and Immunology, San Diego, CA). C57BL/6 (B6) and BALB/c mice (5-6 wk) were
purchased from Harlan Sprague Dawley (Indianapolis, IN). Animals were sex and age
matched for all experiments. All manipulations involving the immunocompromised
mice were performed in laminar flow hood. To prevent bacterial super infections, all
mice received prophylactic treatment with sulfatrim pediatric suspension (Barre
National, Baltimore, MD) at the rate of 5 ml per 200 ml of drinking water. All
experimental procedures were in complete agreement with the Association for
Research in Vision and Ophthalmology (ARVO) resolution on the use of animals in
research.
Virus and reagents

HSV-1

RE

(obtained from the laboratory of Dr. Robert Hendricks, University

of Illinois, Chicago) and HSV - 1 KOS strains were propagated and titrated on
monolayers of Vero cells {ATCC CCL8 1 ) using standard protocols( 1 1 ). HSV- 1

RE

was used for corneal infections and HSV- 1 KOS was used to elicit cutaneous delayed
type hypersensitivity reactions, in vitro lymphoproliferation assays and immunization
of mice. Cyclosporin A (CsA) (Sandimmune, Novartis) was administered
intraperitoneally daily beginning from the day of ocular infection in 1 OOfll volume at
a dose of 50mg/kg ( 1 2, 1 3).
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Corneal HSV Infections and Clinical Observations.

Corneal infections of all mice groups were conducted under deep anesthesia induced
by avertin (Sigma). Mice were scarified on their corneas with a 27- gauge needle, and
a 4 J..Ll drop containing required viral dose was applied to the eye and gently massaged
with the eyelids. The eyes were examined on different days post infection with a slit
lamp biomicroscope (Kowa Co., Nagoya, Japan) and the clinical severity of keratitis
of i ndividually s cored m ice was r ecorded. T he scoring s ystem w as a s follows: + 1 ,
mild corneal haze; +2, moderate corneal opacity or scarring; +3 , severe corneal
opacity, but iris invisible; +4, opaque cornea; and +5, necrotizing stromal keratitis.

Quantification of IFNy production by intracellular staining

To enumerate the IFNy producing CDS+ T cells, intracellular cytokine staining was
6
performed a s previously described ( 14). In b rief, 10 freshly e xplanted splenocytes

and/or draining lymph node cells were cultured in flat bottom 96-well plates. Cells
were left untreated, stimulated with HSV gB(498-SOS) peptide (SSIEFARL), OVA(2S7-264)
peptide ( SIINFEKL ), P 1 4(gpll-4l > peptide ( 1 J..Lg/ 1 06 c ells), o r treated w ith P MA ( 1 0
ng!ml) and ionomycin (500 ng!ml), and incubated for 6hr at 37° C in 5% C02•
Brefeldin A ( 1 0 J.lg/ml) and IL-2 (50 U/ml) was added for the duration of the culture
period. After this period, cell surface staining was performed, followed by
intracellular cytokine staining using a cytoftxlcytoperm kit (Pharmingen, San Diego,
CA) in accordance with the manufacturer's recommendations. PE labeled anti-IFNy
antibodies were

used for intracellular cytokine

Pharmingen).
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staining

(Clone

XMG 1 .2,

Flow cytometry and tetramer staining

Single cell suspensions were prepared fromDLN cells and spleens of mice. For
analysis of HSV reactivity of the P 1 4 RAG-/- and OT- 1 RAG-/- mice, splenocytes
obtained from ocularly infected mice were expanded in vitro for 5 days in the
presence of stimulating peptide (2 f.lg/1 06 cells) and IL-2 (50 U/ml). MHC class I (H2b) tetramers were used to measure SSIEFARL-specific, SIINFEKL specific and P 1 4
specific T cells (Provided by NIAID Tetramer Facility and Dr. Rafi Ahmed, Emory
University, respectively). Cells ( 1 06) were suspended in FACS buffer and stained with
CD8-FITC (Pharmingen) and tetramers. They were incubated for 30 min washed and
analyzed using FACScan and Cell Quest software (Becton Dickenson).

Histopathology and Immunohistochemical staining

Eyes were enucleated and fixed in 1 0% buffered neutral formalin and embedded in
paraffin. Sections (five-micron-thick) were cut and stained with hematoxylin and
eosin. For immunohistochemistry, eyes were frozen in optimum cutting temperature
(OCT) compound (Miles, Elkart, IN). Six-micron-thick sections were cut, air dried,
and fixed in cold acetone for 5 minutes. For detection of viral antigens sections were
blocked with heat inactivated goat serum (Sigma) and incubated with rabbit anti-HSV
anti-serum (Dako Corp, Carpentaria, CA) followed by biotinylated goat anti-rabbit Ab
(Biogenex, San Ramon, CA). For detection of T cells, sections were blocked with 3%
BSA and then incubated with hamster anti-mouse TCR J3 monoclonal antibody
(Pharmingen) followed by biotinylated anti-hamster lgG (Vector Labs, Burlingame,
CA). Sections were then treated with HRP-conjugated streptavidin ( 1 1 1 000 dilution,
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Jackson Immunoresearch Laboratories Inc.) and 3,3 '-diaminobenzidine substrate
(Biogenex, San Ramon, CA), and counter stained with hematoxylin (Sigma).

Statistical Analysis

Wherev�r specified, data obtained were analyzed for statistical significance by
Student' s t test.

RESULTS

Herpetic Stromal Keratitis in CDS+ TCR transgenic mice

Ocular infection of P 1 4 RAG-/- mice, whose peripheral T cells were CD8+ T cells and
recognized LCMV gp33 -4 1 (Dr. B. J. Fowlkes, NIAID-personal communication),
resulted in c linical HSK evident around 7-8 days post infection (Fig 1 , all figures
located in appendix). However, animals usually died of herpetic encephalitis by 1 1 -12
days post infection. In such experiments, around 40% of control B6 animals
developed clinical HSK and none died of herpetic encephalitis. In addition, lesions in
the control immunocompetant mice developed more slowly than in the P 1 4 RAG-/. animals (Fig 1 ) Both CD8+ T cells and viral antigens were present in the stroma of
.

corneal lesions from P14 RAG-/- mice tested histologically at 1 0 days post infection
(Fig 2A and B respectively). In contrast detectable antigen had disappeared from
sections of control B6 animals after the first 2-3 days of infection and was
undetectable in sections showing HSK lesions (data not shown).
Sample animals killed at 1 0 days post infection, were also tested for HSV gB
and LCMV gp33-4 1 peptide specific immune reactivity, measured by both
intracellular IFNy production as well as with specific tetramers following in vitro
expansion. Cells from P 1 4 RAG-/- animals failed to show significant reactivity to the
87

gB p eptide, u nlike c ontrol B 6 m ice w hich showed robust responses ( Table 1 A, a ll
tables l ocated i n appendix). S uch d ata indicate that the P l 4 R AG-/- m ice failed to
respond immunologically to HSV antigens. Mice immunized with UV inactivated
HSV also failed to generate gB peptide specific responses (data not shown).
In a separate experiment, a group of Pl4 RAG-/- and control B6 mice were
immunized with UV inactivated virus 1 0 days prior to ocular infection with HSV -RE.
Animals were followed for clinical signs of HSK and encephalitis. Immunized P l 4
RAG-/- mice all developed HSK of approximately equal severity and time course as
in the non-immune infected Pl4 RAG-/- mice (Fig 1 ). In addition, immunized animals
all died of encephalitis by 1 1 days p.i showing that vaccination failed to induce
immunity in the Pl4 RAG-/- mice. In contrast, detectable clinical lesions did not
occur in immunized B6 animals following HSV ocular infection (Fig 1 ).
Limited experiments were also performed with OT- 1 RAG-/- animals whose
ens+

T cells recognize the OVA2s1-264 peptide. Infected OT-1 RAG-/- animals

developed HSK but with slower kinetics than observed in other strains studied (Fig 1 ).
Moreover, animals lived longer than the usual 1 1 - 1 2 days. Evaluation of lesions
histologically and immune reactivity of splenocytes was tested 1 3 days post infection.
Typical HSK lesions, with both ens+ T cells and viral antigen present in the stroma,
were evident in corneal sections of OT- 1 RAG-/- infected mice (Fig 2 e and n
respectively). Moreover lymphocytes from HSV infected OT- 1 RAG-/- animals
stimulated with HSV g B peptide failed to develop significant specific responses as
tested both by intracellular cytokine expression (for IFNy) or tetramer analysis (Table
1 B). However lymphocytes from these mice responded positively to the OVA2 5 7_264

peptide {Table 1 B).

ss

T cell activation requirements for HSK development in P14 RAG-/- mice

TCR activation of cells is subject to inhibition by the drug Cyclosporin A (CsA) ( 1 5).
To determine if HSK lesions in the transgenic system were mediated by TCR
stimulation o f the transgenic T cells, the effects of C sA on I esion expression w ere
measured. As recorded in Fig 3A, CsA treatment had no significant inhibitory effect
on the expression of lesions in the HSV infected P l 4 RAG-/- mice. In contrast, in
control immunocompetent BALB/c mice, in which t he pathogenesis o f HSK l ikely
involves TCR mediated stimulation of ingressing T cells ( 1 6), CsA was markedly
inhibitory o n I esion progression a nd severity (Fig 3B). T hese r esults are c onsistent
with the notion that the mechanism by which transgenic T cells become activated to
participate in HSK lesions may differ from that in immunocompetent animals.

DISCUSSION

Herpes simplex virus induced stromal keratitis is an immunoinflammatory reaction in
the cornea organized primarily by CD4+ T cells (3). Currently the identity of antigens
recognized by the T cells involved in lesion induction remains unresolved. The logical
idea that viral proteins provide the nominal antigens recognized has been questioned
by the observation that HSK can be induced in mice whose CD4+ T cells lacked
detectable reactivity to viral antigens (7-9). Initial reports came from studies in TCR
transgenic (TCR Tg) SCID or RAG-/- mice where the bulk of T cells recognized the
OVA323.339 peptide (7 -9). The present report demonstrates that HSK can be induced in
additional TCR Tg RAG-/- mice which react with different peptides but which also
fail to show detectable reactivity to HSV. The models were two TCR Tg RAG-/- mice
that possessed only CDS+ T cells. Such cells reacted with the Lymphocytic
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choriomeningitis virus P 14(gp33-4I) peptide and the OVA(2s 7-264) peptide respectively.
These TeR Tg RAG-/- strains showed no detectable cross reactivity to HSV antigens
and animals failed to develop HSV specific immunity upon infection or immunization
with viral antigens. Our results further support the notion that T cell dependent ocular
inflammatory lesions initiated by HSV infection can be mediated by ens+ T cells that
do n ot r ecognize n ominal antigens d erived from v iral proteins. This m echanism o f
immunopathology has been referred to as bystander activation (7-9) and may be the
consequence of non-TeR mediated activation of T cells.
Initial reports of bystander activation HSK in the DO 1 1 . 1 0 SeiD and RAG-/
mice could not exclude the possibility that some low level c ross reactivity e xisted
between the OVA peptide and peptides derived from one or more of the
approximately SO proteins encoded by HSV. Thus the lesions could result from viral
epitope peptide activation of the OVA specific en4+ T cells. Aside from the fact that
no cross reactivity was demonstrable, a search of the gene bank revealed no molecular
mimics of t he s equence that e ncoded the 0 VA p eptide( 14 ) 0 ur m odel strains h ad
.

+
+
transgenic ens T cells and ens T cells, in recognizing shorter peptides in a closed
MHe cleft, may be expected to show less cross-reactivity than do en4+ T cells. We
contend that the observation that ens+ TeR Tg RAG-/- animals whose T cells
recognize different nominal antigens, but not HSV, makes it even less likely that the
lesion orchestrating T cells are reacting with peptide epitopes derived from HSV.
Also a rguing a gainst c ross reactivity w as the o bservation that a 11 T eR Tg RAG-/
animal models studied were unable to control HSV infection and that the pattern of
immunological and clinical events were unchanged following preimmunization with
HSV. This stands in contrast to the situation in immunocompetant mice, as
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demonstrated in this report, where preimmunization protects against the development
of HSK following subsequent ocular infection with virulent HSV( 1 7, 1 8).
We and others have demonstrated that lesions resulting from HSV infection of the
cornea are T cell mediated (1 9-22). In immunocompetant animals, as well as in
previously studied TCR Tg models, the T cells involved in HSK have been
·

predominantly of the CD4+ phenotype. In fact few CD8 + T cells infiltrate ocular
lesions at least in the BALB/c mice(23). Moreover with adoptive transfer studies with
immune T cell subsets, lesions can only be induced with CD4+ T cells, with CD8+
cells actually serving to modulate rather than mediate HSK(8, 2 1 ). The finding that
transgenic CD8 + T cells could mediate HSK in the bystander activation model was in
consequence unexpected. Furthermore at present it is not clear how either the
transgenic CD4+ or CD8+ T cells are activated to mediate lesions if recognition of a
specific viral derived epitope is not involved. Previous reports, however, documented
situations in which either naive or memory cells may be activated without exogenous
application of cognate antigen. One now well studied example is the homeostatic
expansion and activation of n aive cells i nto p seudo-memory c ells t hat occurs u pon
transfer of naive T cells into lymphopenic animals(24, 25). The expanded cells take
on an activation phenotype and may participate in inflammatory reactions. Thus
previously we have shown that naive transgenic CD4+ T cells transferred into SCID
recipients underwent homeostatic activation in 2-3 weeks and animals subsequently
infected with HSV were significantly more susceptible to HSK than were recipients
infected soon after cell transfer ( 1 4).
Other reports have documented that cells with a memory phenotype may be
activated by exposure to cytokines without the addition of exogenous nominal antigen
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(26). In the HSV system described in the report, we suggest that the T cells which
enter the cornea in response to the inflammatory reaction set off by HSV, are exposed
to multiple signaling molecules that may activate them directly, rather than by TCR
mediated signaling, to participate in the inflammatory response. Most likely the initial
source of some of the proinflammatory cytokines are the infected cells themselves.
There are several likely candidates. IL-6, known to play a role in amplifying
leukocyte accumulation at sites of inflammation, by augmenting the local production
of chemokines (27) has been previously shown to be produced in HSV infected
corneas (28). Recent observations also point to the fact that this cytokine is an
important participant in the cytokine cascade triggered by HSV corneal infection(29).
Subsequently the main source may be accessory cells such as dendritic cells that
respond to factors released from viral infected cells, such as stress proteins and viral
DNA. Accordingly, HSV DNA contains numerous bioactive CpG motifs, that could
cause dendritic cells to produce proinflammatory cytokines IL- 1 2 and IL-1 8 known to
directly activate T cells(1 5).
Our results also provide evidence that events involved in activating transgenic
T cells to m ediate HSK differ from those o ccurring in immunocompetent a nimals.
Accordingly, we observed that HSK in the P14 RAG-/- mice was unaffected by
treatment with the drug cyclosropin A. In contrast, HSK in immunocompetent control
animals, where early events at least are considered as mediated by TCR activation of
viral antigen specific T cells( 1 6), was markedly diminished by cyclosporin A
treatment. We interpret such results to mean that mechanisms of activation of
transgenic T cells in HSK lesions occurs other than by TCR activation. Presumably
one or more cytokines or chemokines are involved with cytokine activation of T cells
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unaffected by cyclosporin A. Thus as reported by others, direct activation of T cells
by IL- 1 2/IL-1 8 cannot be inhibited by cyclosporin A treatment (1 5). It will be
important to understand how activation of T cells resulting in HSK, is mediated at the
molecular level. Such investigation is currently underway in our laboratory.
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Figure 1 . CDS+ TCR transgenic mice develop HSK and die o f encephalitis
despite UV-HSV immunization.

P l 4 RAG-/- mice and C57BU6 mice (n=5) were immunized with UV-HSV i.p ( 1 0

7

7
pfu prior to UV irradation) 1 0 days before infection on scarified corneas (5x 1 0 pfu
HSV- 1 RE). S imilar dose was used for the OT- 1 RAG-/- mice. Unimmunized P l 4
RAG-/- and C57BL/6 mice (n=S) were used as controls. Mice were scored clinically

for HSK on a score of 0-5 as described in materials and methods. Data plotted for P 14
RAG-/- and OT-1 RAG-/- mice are for days 3, 5, 7 and 1 0 post infection. These
animals succumbed to encephalitis by day 1 0-1 1 post infection. Data plotted for
C57BU6 mice are for days 3 , 5, 7, 1 0, 14 and 20 post infection. Results are expressed
as mean clinical score ± SD. * 40% of mice developed disease.
Reprinted with from Cellular Immunology, 2 1 9, Banerjee, K., Desphande, S., Zheng,
M., Kumaraguru, U., Schoenberger, S. P. and Rouse, B. T. 1 08- 1 1 8., 2002, with
permission from Elsevier.
1 00

.
Figure 2. lmunohistochemistry of infected CDS+ TCR transgenic mouse corneas
shows infiltrating T cells and persisting viral antigens.

(A & C). P14 RAG-/- (A) and OT- 1 RAG-/- (C) eyes were enucleated on day 1 0 and
day 1 3 respectively post infection and were sectioned and processed for
immunohistochemistry for T cell detection (hamster anti mouse TCR f3 antibody
Pharmingen) as described in materials . and methods. Arrows show the presence of
infiltrating T cells in the stroma (as detected by brown staining). Sections were
counterstained with haematoxylin.
(B & D). Arrows show viral antigen staining in the corneal stroma of P 1 4 RAG-/- (B)
and OT- 1 RAG-/- (D) mice.
Reprinted with from Cellular Immunology, 2 1 9, Banerjee, K., Desphande, S., Zheng,
M., Kumaraguru, U., Schoenberger, S. P. and Rouse, B. T. 1 08-1 1 8., 2002, with
permission from Elsevier.
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Figure 3. HSK kinetics in BALB/c and P14 RAG-/- transgenic mice treated with
cyclosporin A (CsA).

7
Groups of P 14 RAG-/- and BALB/c (n=4) infected with HSV-1 RE (5x1 0 pfu for
5
P 1 4 RAG-/- and 5x1 0 pfu for BALB/c) on scarified corneas were treated with
cyclosporin A (50 mg/kg) intraperitoneally daily. P 1 4 RAG-/- mice (A) and BALB/c
mice (B) were scored clinically for HSK on a score of 0-5 as described in materials
and methods. Data plotted for P 1 4 RAG-/- mice are for days 3, 5, 7 and 10 post
infection. These animals succumbed to encephalitis by day 10-12 post infection. The
data plotted for BALB/c mice are for days 3 , 5, 7, 10, 14 and 21 post infection.
Results are expressed as mean clinical score ± SD.
Reprinted with from Cellular Immunology, 2 1 9, Banerjee, K., Desphande, S., Zheng,
M., Kumaraguru, U., Schoenberger, S. P. and Rouse, B. T. 1 08-1 1 8 ., 2002, with
permission from Elsevier.
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Table 1. P14 RAG-/- and OT-1 RAG-/- mice show no reactivity to HSV

Frequency of CD8 response
o/o Tetramer positiveb

0/o

Mice

Stimulating
peptide

A.
P14 RAG-/-

gB(491-505)
P14<Jp3J-4t)

C57BL/6

gB(491-SOS)

intracellular
cytokine
positive•

0

P1 4(1p33-tt)

gB(49s-sos)

-

0.3 ± 0.2

17 ± 2.3

91 ± 3.5

0

6. 1 ± 1 .4

-

7.5 ± 2
-

P14<Jp33-4t)

0. 8 ± 0. 2

1 ± 0.6

B.
OT-1 RAG-/-

g8(498-50S)
0v�157-164)

C57BL/6

gB(491-SOS)
ov�157-164)

0

-

0

1 1 .6 ± 2. 1

89 ± 3

0

5.8 ± 1 . 1

0

8.7 ± 1 .3

0

0

I

-

Mice ocularly infected with HSV-RE were terminated on day 1 0 (A) and on day 1 3
(B) post infection and their splenocytes used for intracellular cytokine assay and for
tetramer analysis.
(-) Not done
a In v itro s timulation o f 1 0 6 s plenocytes for 6 hours i n the presence o f stimulating
peptide, IL-2 (50 U/ml) and brefeldin A (10 Jlg/ml)
b In vitro expansion for 5 days in the presence of stimulating peptide and IL-2 (50

U/ml)
Reprinted from Cellular Immunology, 2 1 9, Banerjee, K. , Desphande, S., Zheng, M.,
Kumaraguru, U., Schoenberger, S. P. and Rouse, B. T. 1 08-1 1 8., 2002, with
permission from Elsevier.
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EVALUATION OF THE ROLES OF HSV
REACTIVE AND UNREACTIVE CDS+ T CELLS IN
HSK PATHOGENESIS
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ABSTRACT

Herpetic stromal keratitis (HSK), resulting from corneal HSV -1 infection,
represents a T cell mediated immuno-pathologic lesion. The identity of the antigens
recognized by the T cells remains unresolved. Transgenic mice with T lymphocytes
unresponsive to the viral antigens develop corneal pathology and both ens+ and
CD4+ T cells can enter the cornea without the need for virus recognition (bystander
activation). U sing a C D8+ T cell transgenic m ouse model we investigated whether
recruitment also extends to virus reactive CD8+ T cells. Adoptively transferred virus
reactive CD8+ T cells protected ocularly infected mice from encephalitis. In animals
that developed severe HSK lesions, only HSV non-reactive CD8+ T cells infiltrated
the cornea. HSV reactive CD8+ T cells, on the other hand, were detectable i n the
secondary lymphoid organs, the trigeminal ganglion and the brain. Our results
indicate that after corneal HSV infection, bystander mechanisms activate and recruit
non-HSV reactive, but not virus reactive, pathogenic CD8+ T cells to corneas. Virus
reactive CD8+ T cells are recruited to both the central and peripheral nervous system
where they function to clear virus or presumably prevent virus reactivation and
achieve both protection and HSK modulation.

INTRODUCTION

Herpetic Stromal Keratitis (HSK), resulting from infection of the cornea with
Herpes Simplex virus type 1 (HSV- 1 ), represents a leading cause of infectious
blindness in the western world ( 1 ) Lesions are considered to be immuno-pathological
.

and once a clinical episode occurs patients frequently are placed on long term
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corticosteroid therapy (2), which helps prevent clinical recurrences. Whereas human
HSK is considered as a T cell mediated immuno-inflammatory lesion, definite
evidence for such a mechanism comes from animal studies. Most studies in the mouse
model indicate a primary role for en4 + T cells of the Th1 phenotype (3-g). The
identity of target antigens recognized by the lesion orchestrating en4 + T cells remains
unclear. Thus only a minority of T cells in ocular lesions react with viral antigens,
leading to the suggestion that most inflammatory T cells in lesions represent
bystanders (9-14). In some models it is possible to induce HSK lesions with either
eng + or en4+ T cells that are judged to be bystanders alone(9, 1 2-14). Thus in these
TeR transgenic models, the T cells lacked demonstrable reactivity with any antigens.
Nevertheless T cells were needed since animals lacking such cells fail to express HSK
lesions (5, 6, 1 5).
In this report, using the eng+ T cell bystander model, we have attempted to
define the role of the HSV specific eng + T cells in HSK pathogenesis. Previous
reports indicate a protective role for HSV immune eng + T cells with respect to ocular
HSV infection (3, 5, 6, 1 3). This interpretation emerged from the finding that Sein
mice given an adoptive transfer of HSV immune eng+ T cells

from

immunocompetent mice protected ocularly infected mice from encephalitis and
extended their life span dramatically, but did not lead to HSK lesions (3, 5, 6, 1 3). In
light of our recent findings with the recruitment of non-HSV-specific eng + T cells
into corneas we investigated whether such recruitment extends to HSV immune eng

+

T cells using the eng + T cell transgenic mouse model (OT- 1 RAG-/- mice).
Adoptively transferred, purified, immune eng + T cells protected ocularly infected
mice from encephalitis that was presumably via a combination of the ability of these
1 06

cells to clear virus from the CNS and prevent virus reactivation from the peripheral
nervous s ystem (trigeminal g anglion, T G). In mice that received cells 3 days after
infection, survived encephalitis and developed severe HSK lesions, CD8 + T cells
infiltrating the cornea were identified to be HSV non-reactive. HSV reactive CD8+ T
cells, on the other hand, were detectable in the secondary lymphoid organs, the
trigeminal ganglion and the brain. Thus, after corneal HSV infection, bystander
mechanisms a ctivate a nd r ecruit non-HSV r eactive, but n ot v irus r eactive, CD8+ T
cells to corneas and these participate in HSK pathogenesis. Virus reactive CD8+ T
cells are recruited to both the central and peripheral nervous system where they
function· to clear virus or presumably prevent virus reactivation and achieve both
protection and HSK modulation.

MATERIALS AND METH ODS

Mice

Five to six week old female mice were used for the experiments. OT- 1 RAG-/CD45 . 1 mice were produced in the laboratory of Dr. Stephen Schoenberger (La Jolla
Institute of Allergy and Immunology, San Diego, CA). These mice are referred to in
the text as OT- 1 RAG-/- mice. HSV specific TCR transgenic mice (gBT- 1 . 1 ) were
produced in the laboratory of Dr. Francis Carbone (University of Melbourne,
Melbourne, Australia) ( 1 6). C57BU6 (B6) mice (CD45.2) were purchased from
Harlan-Sprague-Dawley (Indianapolis, IN). Animals were age and sex matched for all
experiments. All manipulations involving immunocompromised mice were performed
in laminar flow hood. To prevent bacterial super infections, mice received
prophylactic treatment, starting one day prior
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to

· corneal infection, with sulfatrim

pediatric suspension (Barre National, Baltimore, MD) at the rate of Sml per 200ml of
drinking water. All experimental procedures were in complete agreement with the
Association of Research in Vision and Ophthalmology (ARVO) resolution on the use
of animals in research.

Virus

HSV -1 RE (obtained from the laboratory of Dr. Robert Hendricks, University of
Illinois, Chicago) and KOS strains were propagated and titrated on monolayers of
Vero cells (ATCC CCL8 1) using standard protocols ( 1 7). HSV- 1 RE was used for
corneal infections and HSV- 1 KOS was used to immunize mice and elicit cutaneous
delayed type hypersensitivity reactions.

Corneal HSV infections and clinical observation

Corneal infections of all mice groups were conducted under deep anesthesia induced
by avertin (Sigma). Mice were scarified on their corneas with a 27 gauge needle and a
4J.ll drop containing 5 x 1 06 pfu of HSV- 1 RE was applied to the eye a nd gently

massaged with the eyelids. The eyes were examined on different days post infection
with a s lit I amp b iomicroscope ( Kowa, Nagoya, J apan) and the clinical severity o f
keratitis of individually scored mice was recorded. The scoring system was as
follows: +1 , mild corneal haze; +2, moderate corneal opacity or scarring; +3, severe
corneal opacity, but iris invisible; +4, opaque cornea; and +5, necrotizing stromal
keratitis.
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Virus recovery and titration

Eye swabs w ere t aken from infected c orneas ( four e yes/group) u sing s terile swabs
soaked in DMEM containing with 1 OIU/ml penicillin and 1 OOJ.!g/ml streptomycin.
Swabs were put in sterile tubes containing DMEM and stored at -S0° C. For detection
of virus, samples were thawed and vortexed. Duplicate 200J.1l aliquots of dilutions of
each sample were plated on vero cells grown to confluence in 24 well plates at 37° C
in 5% C02 for 1 hr 30 min. Medium was aspirated and 500J.1l of 2x DMEM containing
1 % low-melting point agarose was added to each well. Titers were calculated as log10
pfu/ml as per standard protocol ( 1 7).

Adoptive transfer of HSV immune CDS+ T cells

To generate HSV immune CDS+ T cells, B6 and gBTI. 1 mice were injected with 5 x
1 06 pfu of HSV- 1 KOS into the footpad. Single cell suspensions of pooled spleens
and popliteal lymph nodes were prepared from immunized mice 7-S days later and
CDS+ T cells were purified using a mouse CDS subset column (R & D systems,
Minneapolis, MN). By flow cytometry analysis, the purified population consisted of
SO% CDS+ T cells with no detectable CD4+ T cells. Approximately 9% (B6) and 50%
(gBT-1. 1 ) of the CDS+ T cells produced IFNy upon re-stimulation to the gB49s-sos
immunodominant epitope of HSV, measured by intracellular IFNy production
(measured prior to purification from cell samples taken from pooled splenocyte and
DLN single cell suspensions. See below for details). Ocularly infected OT-1 RAG-/
animals received an intravenous injection of 5 x 1 06 purified cells at 24 (referred to in
the figures as OT- 1 RAG-/-: CDS 24hr) and 72 hr (referred to in the figures as OT-1
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RAG-/-: CD8 72hr. For cells from gBT-1. 1 mice referred to as OT-1 RAG-/-: gBT-1. 1
CD8 72hr) post infection.

Delayed type hypersensitivity (DTH)

At indicated time points after corneal HSV-1 infection, UV inactivated HSV (1 05 pfu
prior to UV inactivation) was injected in 20J.!l of PBS in the right ear pinna of
anesthetized mice. As a control vero cell extract was injected in the left ear pinna. Ear
thickness was measured 48 hr post injection with a screw gauge meter (Oditest; H. C.
Kropelin GhBH, Schluechtem, Germany) as described elsewhere (9). The mean
increase in ear thickness before and after injection was calculated and expressed as
2
1 0- mm.

Cellular analysis and flow cytometry

a. Surface staining for the detection of adoptively transferred CDB+ T cells. Single
cell suspensions were prepared from spleen and draining lymph nodes (DLN) of mice.
The draining lymph nodes that were used for cellular analysis were the mandibular
and the superficial cervical lymph nodes. Whole brains were minced and single cell
suspensions were made by passing minced tissue through a 70Jlm nylon cell strainer.
Isolated TGs were pooled, minced and digested in 1 mg/ml collagenase/dispase
(Roche Diagnostics, Mannheim, Germany) for l hr 30 mins followed by two washes
in PBS. Surface staining of cells was carried out in flow cytometry buffer ( l x PBS
with 3% FCS and 0. 1 o/o Sodium Azide). Viable cells ( 1 0 6) were blocked with Fe
Block (Clone 2.4 G2, Pharmingen). Cells were double stained with FITC labeled antiCD8a (Clone 53-6.7, Pharmingen) and biotin labeled anti-CD45 . 1 (clone A20,
Pharmingen) (host cells) or anti-CD45.2 (clone 1 04, Pharmingen) (Donor cells).
1 10

Biotin labeled antibodies was detected by further incubation of cells with a 1 /200
dilution of streptavidin-PerCP (Pharmingen). Events were collected on FACScan
(Becton-Dickinson, San Jose, CA) and analysed using Cellquest version 3 .0 (Becton
Dickinson, San Jose, CA).

b. Q uantification of IFNy production by intracellular s taining: T o enumerate I FNy
producing CD8+ T cells, intracellular cytokine staining was performed as previously
described ( 1 2). In brief, 1 06 splenocytes or DLN cells were cultured in flat bottom 96well plates. Cells were left untreated, stimulated with HSV gB498•505 peptide
(SSIEFARL), OVA2s1-264 peptide (SIINFEKL) ( 1 J.Lg/1 06 cells), or treated with PMA
( 1 0nglml) and ionomycin ( 500ng/ml) and incubated for 6hrs at 37° C in 5% C02.
Brefeldin A ( l OJ.Lg/ml) and IL-2 (50 U/ml) was added for the duration of the culture
period. After this period, cell surface staining was performed as described above. This
was followed by intracellular cytokine staining using a cytofix/cytoperm kit
(Pharmingen,

San

Diego,

CA)

in

accordance

with

the

manufacturer's

recommendations. PE labeled anti-IFNy antibody was used for intracellular cytokine
staining (clone XMG 1 .2, Pharmingen). Events were collected on FACScan (Becton
Dickinson, San Jose, CA) and analysed using Cellquest version 3.0 (Becton
Dickinson, San Jose, CA).

.
Histopathology, lmmunohistochemistry and Immunofluorescence

Eyes were enucleated and fixed in 1 0% buffered neutral formalin and embedded in
paraffin. Sections (SJ.!ffi thick) were cut, deparaffinized and stained with haematoxylin
and eosin. For i mmunohistochemistry a nd i mmunofluorescence analysis, eyes w ere
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enucleated at indicated time points, frozen in optimum cutting temperature (OCT)
compound (Miles, Elkart, IN). Six micron thick sections were cut, air dried and fixed
in acetone:methanol (1 : 1 ) at -20° C for 1 0 min. For detection of viral antigens
sections were blocked with 5% BSA in PBS containing 1 :200 dilution of Fe block (2
hrs) and incubated with rabbit anti-HSV serum ( 1 0 min) (Dako, Carpentaria, CA)
followed by biotinylated goat anti-rabbit Ab (20 min) (Biogenex, San Ramon, CA).
Sections were then treated with HRP-conjugated streptavidin for 45 min (111 000
dilution,

Jackson

Immunoresearch

Laboratories)

followed

by

3,

3'

diaminobenzidine substrate (Biogenex, San Ramon, CA) and counterstained with
haematoxylin (Richard Allen Scientific, Kalamazoo, MI).
For immunofluorescence endogenous biotin was blocked in acetone:methanol
fixed frozen sections with endogenous biotin-blocking kit (Molecular probes, Eugene,
OR). This was followed by blocking with 5% BSA-PBS-0.05% Tween 20 containing
11200 dilution of Fe Block (clone 2.402, Pharmingen) for 2 hrs. Antibodies used for
staining were anti-CD8-FITC (5 J.tg/ml) (Clone 53-6.7, Pharmingen) and biotin labeled
anti-CD45.2 (1 OJ!g/ml) (Clone 104, Pharmingen). Antibody dilutions were made in
1% BSA-PBS. After incubating overnight at 4° C slides were washed �horoughly in
PBS and Streptavidin conjugated Alexa Fluor 546 (1 Jlg/ml) (Molecular Probes,
Eugene, OR) in 1% BSA-PBS was added for 1hr at room temperature. Slides were
mounted with Vectashield without propidium iodide

(Vector Laboratories,

Burlingame, CA). For slides single stained with FITC labeled antibodies, propidium
iodide was used a counterstain (Vectashield with propidium iodide, Vector
laboratories, Burlingame, CA). Images were captured with a Leica SP2 Laser
scanning confocal microscope.
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Statistical analysis

Wherever specified, data obtained were analysed for statistical significance by a
standard students t test.

RESULTS

OT-1 RAG-/- mice are protected from lethal HSV induced encephalitis by HSV
immune CDS+ T cells

We have previously shown that CD8+ T cells transgenic mice develop typical HSK
lesions upon ocular infection with HSV- 1 and transgenic CD8+ T cells (specific

to

either the LCMV P14 or the OVA2s7-264 epitope) can be found in such lesions ( 1 2).
However, in the a bsence of the full repertoire of immune c ompetent cells, HSV-1
induced encephalitis results in death of such mice within 1 2 days p. i. These results
were confirmed in the present study with the OT- 1 RAG-/- CD45 . 1 transgenic mice.
Indeed, all mice succumbed to encephalitis with an ocular infection dose 5x1 06 pfu of
HSV- 1

RE

strain by day 1 2 p. i., a dose that failed to have any impact on the survival

of control C57BU6 (B6) mice (Fig. 1 , for all figures see appendix). Such mice also
developed characteristic HSK lesions at the time of their death (see below).
Utilizing this characteristic of the transgenic non-HSV specific CD8 system
we sought to assess the contribution of HSV immune CD8+ T cells to both survival
and HSK development in such mice. Purified CD8+ T cells from HSV infected B6
mice (CD45 .2) were adoptively t ransferred i nto O T- 1 R AG-/- animals at two time
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points post ocular infection and survival of animals was monitored over a 25 day
period post ocular infection (the last time point analyzed).
Interestingly, adoptive transfers at both 24 and 72 hr p. i. protected mice from
encephalitis (Fig 1). In mice that survived well beyond 1 2 days p. i. no visible clinical
sign of encephalitis was evident. From two separate experiments, 6 of 8 (75%) and 7
of 8 (88%) mice from the 24 and 72 hr adoptively transferred groups survived
encephalitis. However, though control B6 animals showed normal DTH responses to
viral antigens, no such response was demonstrable in transgenic animals receiving
immune cells and surviving lethal encephalitis (Fig 2), and re-ascertains the inability
of CD8 +, but not CD4+ T cells to participate in DTH reactions ( 1 8).
Thus HSV immune CD8 + T cells are protective and prevent the development
of lethal HSV induced encephalitis.

+

Ocular virus clearance in mice receiving immune CDS T cells

Two separate assays were used to determine the clearance of HSV from infected eyes
of different groups of transgenic animals. As evident from Fig. 3 clearance of both
infectious virus and viral antigens was impaired in mice not receiving immune cells,
but succumbing to encephalitis. As measured on day 8 p. i. replicating virus was still
detectable in eye swabs from OT-1 RAG-/- animals that did not receive any immune
cells (Fig 3A). In control B6 mice infectious virus was no longer detectable in eye
swabs from day 6 p. i. (data not shown). When ocular sections of such mice were
processed at day 1 2 p. i., for the d etection of v iral antigens, a ntigens w ere c learly
detectable both in the epithelium and in the stromal layers of the cornea (Fig 3B). In
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control B6 mice, antigens were only detectable in the epithelium till day

5

p. i. (data

not shown).
In marked contrast, infectious virus was undetectable from corneas of most of
the ocularly infected

OT- 1

RAG-/- mice that received the immune CDS+

T

cells. At

day S p. i ., while infectious virus was readily isolated from the mice not receiving
cells, eye swabs from a majority of the eyes of OT- 1 RAG-/- mice receiving cells at
both 24 and 72 hr p. i ., and eventually surviving lethal encephalitis, failed to show any
evidence of replicating virus (Fig 3A). In addition, eyes from mice that were protected
from encephalitis by the adoptively transferred cells (day 1 2 p. i .), did not reveal the
presence of viral antigens (Fig 3 C & D). However, a dense infiltrate of inflammatory
cells was c learly e vident i n corneas o f m ice receiving cells at 7 2 h rs ( Fig 3D) b ut
mostly absent from corneas of mice receiving them at 24 hrs (Fig 3C).
These results indicate that the HSV immune CDS+

T

cells facilitate virus

clearance from infected corneas.

HSV immune CDS+ T cells modulate HSK development

The severity of HSK lesions depends on clearance of virus/viral antigens from
infected corneas (9). Since, adoptive transfer of the immune

ens+ T

cells had an

effect on the clearance of ocular HSV from infected corneas of OT- 1 RAG-/- mice, it
was i nteresting t o s ee how H SK I esions might be a ffected i n such m ice. I ndeed, a
difference was noted in the development of HSK lesions in mice that received
immune ens+ T cells at different times points post infection.

115 .

Firstly, we confirmed the development of typical HSK lesions in OT- 1 RAG-/
mice. By the time all of these animals had succumbed to encephalitis (day 12 p. i.),
the incidence of HSK lesions was approximately 80% (Fig 4 A & B). When
visualized with a slit lamp microscope, typical corneal opacification and growth of
blood vessels was seen from the limbus (Fig 4C). Histopathologically, the lesions
showed inflammatory cell infiltrates and pathology consistent with typical HSK
lesions (Fig SA). Interestingly, very similar disease kinetics was seen in mice that
received cells at 72 hr p . i. ( Fig 4 A). B y d ay 1 2, 45% of eyes from such a nimals
showed c linically e vident H SK I esions, a nd a verage d isease scores w ere s imilar to
that in mice that did not receive cells (Fig 4B). However, in mice that received cells at
24 hrs p. i. lesion development was slower and average scores were 2 fold lower than
in mice that did not receive cells or received them at 72 hrs p. i. (Fig 4 A and B).
HSK lesions were then monitored in mice that survived encephalitis. In mice
that received the c ells at 7 2 hrs p. i., and showed clinically evident signs of H SK
development at day 12 p. i., lesions developed further or persisted throughout the
course of the study (Fig 4A) and at day 25, which was the last time point analyzed,
the HSK incidence was 64% (Fig 4B). The corneas of many of such eyes had severe
pathology, with necrosis and scarification and the development of blood vessels
reaching the centre of the cornea and massive infiltration of inflammatory cells (Fig
4C and SB). In contrast to these findings, lesion development remained slow, or
regressed, in mice that received cells at 24 hrs (Fig 4A) and at the end of the study
period the incidence was greater than 3 fold lower (Fig 4B). Eyes from this group
showed very mild pathological changes at day 25 p. i. (Fig SC). Thus CD8 + T cells
regulate HSK lesion development. This depends on the time of adoptive transfer post
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infection and is related with the ability of such cells to facilitate virus clearance from
infected corneas.

Bystander CDS+T cells mediate HSK lesions

As evident from the above mentioned HSK studies, OT-1 RAG-/- mice that did not
receive immune cells succumbe� to encephalitis by day 1 2 p. i., at which time a
majority of the infected eyes showed clinical signs of HSK lesions. T cells infiltrating
corneas in such mice were CDS+ T cells, as judged by immunohistochemical analysis
of frozen ocular sections (Fig 6A). Since greater than 9S% of the OT-1 RAG-/- T cell
population is dominated by CDS+ T cells that recognize the OVA257•264 epitope and do
not show a ny cross r eactivity t o H SV a ntigens ( 1 2), it w as obvious t hat t he lesion
infiltrating T cells were non-HSV specific. Thus HSK lesions were orchestrated by
bystander activated CDS+ T cells, since RAG-/- mice succumb to encephalitis at
around the same time point, but do not show evidence of HSK lesions (data not
shown, ( 1 4)).
The presence of CDS+ T cells in lesions from mice that had received immune
CDS+ T cells at 72 hrs p. i., survived encephalitis, and developed severe HSK lesions
by day 25 p. i. was determined by a similar procedure. Indeed, as evident from Fig.
6B, large numbers of CDS+ T cells were demonstrable at this time point. Two color
immunofluorescence and c onfocal microscopy w as used to define the host a nd t he
donor CDS+ T cells in corneal lesions. Serial ocular sections were stained with anti
COS and anti-CD45 .2 (donor cells). As revealed by this assay and evident from Fig
6C, visually, a majority of the CDS+ T cells were of the host origin (i. e. non-HSV
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specific). A few, very rare, scattered CDS + cells were found to be of donor origin. At
this time very few of the CDS+ T cells in the DLN and the spleen of such mice were
of donor origin (Fig. 7).

In addition, upon re-stimulation with the HSV

immunodominant gB 498.505 peptide none (in the DLN) or a negligible (in the spleen)
number of such surviving transferees were capable of IFND production revealing the
+
absence of functional CDS T cells reactive to HSV (Fig 7). Thus, by extrapolation,
the few rare donor cells in the cornea at this time point were likely to be non-HSV
specific as well.
Further investigations were carried out to determine whether in the presence of
large n�mber of HSV reactive CDS + T cells in the periphery, such cells could be
found in the cornea. For this we utilized HSV immune CDS+ T cells from the gBT-I. l
mice. G reater t han 9S% of C DS+ T c ells i n s uch m ice h ave T CRs r ecognizing the
immunodominant HSV -1 gB498.505 epitope ( 1 6). OT -1 RAG-/- mice received an
adoptive transfer of HSV immune gBT -1 . 1 CDS+ T cells 72 hours after ocular
infection. Adoptively transferred CDS+ T cells were readily demonstrable 1 2 days p.
i., in both spleens and DLN (total number of recovered CDS+ T cells in DLN
approximately double that seen in the spleen, data not shown) and with greater than
50o/o of the transferees capable of IFNy production upon re-stimulation with the
immunodominant peptide (Fig 7). Interestingly, even at this time point no HSV
reactive donor cells were detectable in corneas, even though as expected there were
host (HSV un-reactive) CDS+ T cells (Fig 6D).
Taken together, our results imply the ability of bystander activated CDS+ T
cells, but not H SV r eactive C DS + T c ells, to migrate to the c ornea and orchestrate
lesion development
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HSV specific CDS+ T cells migrate to the brain and trigeminal ganglion

Additional experiments were carried out to understand the protection from
encephalitis and the modulation of HSK afforded by the HSV immune CDS+ T cells.
Experiments involved analysis of whether such cells could be detectable in the brain
and trigeminal ganglion (TG), based upon the understanding that CDS+ T cells are (1)
involved in CNS viral clearance ( 1 9, 20) and (2) prevent virus reactivation from the
peripheral nervous system after ocular infection (2 1 )
In our experiments, we used the ocularly infected OT- 1 RAG-/- animals that
had received an adoptive transfer of gBT-1. 1 CDS+ T cells 72 hrs after infection (such
mice are protected from HSV induced encephalitis but not from HSK development).
The trigeminal ganglia and brain from such mice were processed on day 1 2 post
infection (9 days after adoptive transfer). Donor HSV reactive cells were evident in
the trigeminal g anglion both by microscopic (Fig 6E) and flow cytometry a nalysis
(Fig 7 ). Interestingly, t he TG a lso c ontained virus non-reactive host C DS+ T c ells,
though outnumbered by the HSV reactive species almost twofold (Fig 7). In addition,
a similar presence of CDS+ T cells was noted in the brains by flow cytometry (Fig 7).
However, the ratio of virus reactive to non-reactive cells in the brain was almost 6 to
1 (Fig 7).
Thus after an ocular HSV infection, virus specific CDS 's migrate to the
trigeminal ganglion and the brain, but not to the cornea. Their presence in the brain
accounts for the protection from encephalitis, presumably through virus clearance.
Further, finding virus specific cells in the TG implies their possible role in controlling
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virus reactivation from this site and anterograde transport to the cornea, since in mice
that received cells very early (24 hrs) corneal virus was cleared and HSK failed to
occur.

DISCUSSION

It is established that T lymphocytes are the crucial mediators in the pathogenesis of
Herpetic Stromal Keratitis (HSK). So far the identity of agonists responsible for the
influx of these critical cells is unclear. Viral proteins, processed and presented by
professional antigen presenting cells {APCs) or even by corneal cells themselves (22),
are unlikely involved in T cell activation since T cells lacking reactivity to viral
antigens can induce HSK {9, 1 1 , 1 2) This mechanism of immunopathology, now well
.

studied in several murine models, is referred to as bystander activation (23) Using
.

these models, it has been shown that HSK can be mediated by both CDS+ (the LCMV
P14 RAG-/- and OT- 1 RAG-/- mouse models for ens+ T cell activation) and Cn4+ T
cells (the 00 1 1 . 1 0 SCID and PCC RAG-/- mouse models for CD4+ T cell activation)
(9, 1 1 - 1 3). In the present report we have used the CDS+ T cell bystander activation
HSK model to evaluate whether signals responsible for bystander activation influence
HSV specific ens+ T cells. Our results indicate that HSV reactive ens+ T cells do
not to migrate to the corneal site of inflammation, a capability possessed mainly by
the non-virus reactive ens+ T cells. However, the former cells appear to facilitate the
control of viral replication in the cornea presumably by preventing virus reactivation
from sites of latency and anterograde transport to the original site of infection. These
results further strengthen the concept that murine HSK is mainly mediated by non-
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HSV specific T cells that are activated by bystander mechanisms a nd confirm the
protective and HSK immunomodulatory role of virus specific CD8+ T cells.
It is evident that in the HSV infected RAG-/- or the SCID there exists a pro
inflammatory environment that overrides regulatory controls. Quiescent cells are
activated, by bystander mechanisms into aggressive effector cells {Taggressors) that
induce HSK lesions. This scenario is reminiscent of the activation of naive T cells
into pseudo-memory cells, when transferred into lymphopenic animals (24). Thus we
have previously shown that if T cells are allowed homeostatic expansion animals
became more susceptible to HSK (4). In addition, other factors such as the lack of
+
regulatory CD4 CD25 + {Tregs) cells have a likely influence. As shown recently, with
the R AG-/- m ouse m odel, i n w hich animals d evelop H SK o nly when reconstituted
+
with aggressor CD4 T cells (25), this is indeed the case. These studies demonstrate
that animals fail to develop HSK lesions when reconstituted with a mixture of Tregs
and Taggresors (25). Another contributing factor is virus persistence and dissemination
into the corneal stroma, as shown in the present report and previously {9, 1 2, 1 3, 26).
Virus derived molecules (proteins, DNA) in the stroma set up a chronic inflammatory
milieu that provides a constant supply of pro-inflammatory molecules (4). If viral
replication induced events occur favorably within the first few days after infection the
stage is set for t he successful d evelopment of H SK lesions. Thus upon t ransfer o f
HSV immune CD8+ T cells, 24 hrs after infection, virus replication was controlled
shortly after, preventing the induction of pro-inflammatory events. This pro
inflammatory milieu was however induced optimally in mice that received cells 3
days later and by extrapolation from our results it appears that optimal induction in
the bystander model requires a replication of 6-8 days p .i. Thus the latter and not the
former mice developed HSK lesions.
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Most likely the sources of the initial pro-inflammatory molecules are the virus
infected corneal cells themselves. Of the several likely candidates, IL-l and IL-6, both
of which have been shown to be involved in cytokine cascades and inflammatory cell
influx (27-29), maybe the initial molecules. Subsequently, after virus replication
events have ceased, as in the case of mice that received cells at 72 hrs, the main
producers of T lymphocyte activating cytokines are infiltrating non-resident DCs or
macrophages that respond to molecules released from virus infected cells. Cytokines
that are thought to be involved in this process are IL- 12 (30) and IFNy (3 1). These
molecules are currently under investigation. Another potential candidate that is
thought to sustain the inflammatory process, possibly through its action on
macrophages and dendritic cells, is HSV DNA. This molecule persists in corneas
throughout the course of murine HSK (32) and contains abundant CpG motifs (33).
Recent evidence

points

to

the

fact

that,

indeed,

CpG

motifs

possess

immunostimulatory capabilities required to drive Th 1 type responses after HSV
infection (33) and cornea infiltrating T cells show the same phenotype (7, 8).
Supporting the role of HSV DNA derived CpG motifs in the bystander phenomenon
is the observation of aggravated HSK lesions in DO 1 1 - 1 0 SCID mice previously
exposed to CpG (9). In addition, CpG has also been shown to be involved in the
formation of new blood vessels (angiogenesis) in the cornea (34) that serve as
conduits for T lymphocytes.
The results from the present study provide insights about the functions of the
HSV specific CD8+ T cells after an ocular HSV -1 infection. First and the most
obvious is presence of HSV reactive CD8+ T cells in the brains and their ability to
protect from lethal encephalitis. As also observed in other HSV -1 models of
encephalitis, indeed, when such cells are present early, but not late in infection, mice
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are protected (20). Several studies, both in vitro and in vivo, have investigated
mechanisms o perational i n the p rotection from uncontrolled v iral r eplication in the
nervous system and have implied non-cytolytic mechanisms involving IFNy (2 1 , 35,
36) and Granzyme A (37). Secondly, these cells are by themselves unable to mediate
HSK, a capability possessed by bystander activated ens+ T cells. This is probably
due to the inability of such cells to migrate to and reach sufficient numbers in the
cornea as evident both from previous studies {3, 6, 1 3) and results presented here.
There could be two possible explanations for the inability of HSV cnss to
enter the cornea. The simplest would be to assume that one or more corneal homing
molecules are different between the two types of ens + T cells. However, the most
probable scenario is that HSV specific cells only migrate to sites that are virus
infected. Thus, shortly after HSV infection, the focus of migration of HSV immune
enss is likely to be the draining lymph nodes associated with the cornea and
trigeminal ganglion {TG) which is also a site of active viral replication and the
induction of inflammatory cytokines (3S). Extensive corneal angiogenesis is lacking
at this stage and being a determining factor in T cell migration to corneas (3 9), even
though the cornea is the site of viral replication, HSV specific ens + T cells are unable
to enter. Eventually during the clinical phase, when conditions become favorable, by
corneal neovascularization, replicating virus or viral antigens are no longer detectable
in the cornea making it unnecessary for these cells to extravasate into corneal tissues.
However, in our experiments, in some instances few rare donor cells were indeed
noted in the corneas at this stage and we contend that these are probably donor
bystander cnss that comprised 90% of the input population and survived within the
host. Such cells were likely influenced by the bystander signals that effectively
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recruited the OVA specific CD8s into the cornea. Further investigations are ongoing
to substantiate these speculations.
Finally, and most importantly, though unable to migrate to the cornea, CD8+ T
cells facilitate corneal viral clearance. This indirect, remote, mechanism of viral
clearance can be explained by a possible effect that the HSV immune CD8 + T cells
have on neutrophils. The latter cells migrate into corneas shortly after infection and
are involved in viral clearance (40). Previous studies have implied that the cytokine
IFNy is involved in neutrophil extravasation from corneal blood vessels by
upregulating PECAM- 1 expression on vascular endothelial cells (4 1). One likely
scenario is that the immune CD8s were a source of vast amounts of this critical
cytokine, otherwise lacking in the un-reconstituted mice, allowing neutrophils to enter
the cornea through similar integrin up-regulation associated events. This needs further
evaluation. The other possibility that HSV reactive CD8 + T cells might have stopped
reactivation events in the TG is supported by recent observations by the Hendricks
laboratory (2 1 , 36, 42) and in this study. In their ocular infection model, HSV specific
+
CD8 T cells that infiltrate the TG are the dominant population amongst the CD8+ T
cells, persist for months at this site and appear to prevent virus reactivation by
monitoring latently infected neurons by mechanisms involving IFNy (2 1 , 36, 42). In
the immune-compromised mice that we have used, presumably in the absence of a
monitoring system in the TG, the virus repeatedly finds its way back to the original
site of infection and is responsible for a continuous source of inflammatory
molecules. Our results show that indeed these cells can find their way to the TG and
interestingly when given early (24hrs p. i.) prevent HSK. Thus HSK lesions in the
immune-compromised bystander model maybe a result of virus reactivation. This
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speculation is supported by studies that show the inability to induce HSK, in DO 1 1 . 1 0
SCID mice, if infected with a virus that is unable to reactivate from the TG (9).
In conclusion, our results serve . to demonstrate the distinct roles of HSV
specific C D8+ T cells and C D8+ T c ells o f o ther s pecificities with r espect to H SK
pathogenesis. The p icture that emerges from these studies i s t he i mportance o f the
immune CDS + T cell as a modulator of HSK development. Other studies have
demonstrated the increase in HSK severity and the enhanced susceptibility to
encephalitis ( 1 9, 3 1 , 35), in the absence or dysfunction of these cells. Further
investigations will focus on harnessing the functions of these cells and possibly
.
utilizing their potential to develop prophylactic and therapeutic strategies.
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Figure 1. Ocularly infected OT-1 RAG-/- mice receiving HSV immune CDS+ T
cells are protected from death due to herpetic encephalitis.

Mice were infected on scarified corneas with 5x1 06 pfu of HSV- 1 RE. Adoptive
transfer of HSV immune CD8+ T cells was carried out via tail vein at 24 hrs and 72
hrs p. i. Data compiled from two separate experiments consisting of 4 animals in each
group.
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Figure 2. OT-1 RAG-/- mice receiving immune cells fail to mount a DTH
response to HSV.

Ocularly infected mice fro� different groups (n=4) were injected with UV-HSV and
vero cell extract on the left and the right ear pinna respectively. Increase in ear
thickness was measured after 48hrs. Results expressed as mean ± SD. *p < 0.05
a

Antigen was injected on day 23 p. i. and the DTH response measured on day 25 p. i.

b

For OT -1 RAG-/- mice not receiving cells antigens were inj ected on day 8 p. i. and

DTH response was measured ·on day 1 0 p. i.

13 5

Figure 3. Early clearance of virus from corneas of mice receiving immune CDS+
T cells.
A. Viral titers were determined on day 8 p.i. by agarose overlay method from 4 eyes

for each group and expressed as log 10pfu/ml. Results expressed as mean virus titre ±
SD. * p < 0. 05
B, C and D. Immunohistochemistry for the detection of viral antigens (day 1 2 p.i.) in

frozen sections of eyes from OT- 1 RAG-/- (B), OT- 1 RAG-/-: CD8 24 hr (C) and OT1 RAG-/-: CD8 72 hr (D). Arrows show the presence of viral antigen. The substrate
was DAB and counterstaining was done with Hematoxylin. Magnification x200.
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Figure 4. HSK severity in OT-1 RAG-/- mice receiving immune cells.
A.

Kinetics of HSK development. Mice were monitored for development of

lesions by a slit lamp ophthalmoscope (see materials and methods) at the indicated
time points. Results show the mean ± SD for 1 2 eyes (OT- 1 RAG-/- and OT- 1 RAG-/:
CD8 24 hr), 14 eyes (OT- 1 RAG-/-: CD8 72 hr) and 1 6 eyes (B6). *Significant
difference (p<0. 05) compared to OT- 1 RAG-/-: CD8 24 hr eyes.
B.

Results show HSK lesion scores for day 1 2 and day 25 post infection. OT - 1

RAG-/- mice received an adoptive transfer of 5
(o) and 72 hr (

•

x

1 0 6 immune CD8+ T cells at 24 hr

) p.i. Control OT- 1 RAG-/- mice ( .._ ) succumb to viral encephalitis

on day 1 2 p.i. Shown for comparison is disease development in C57BU6 mice ( • ).
Each dot represents the HSK score from one eye. The horizontal bars and figures in
parentheses show the mean for the groups.
C.

Eyes of OT- 1 RAG-/- mice, not receiving immune CD8s and succumbing to

encephalitis by day 1 2 p.i., show evidence of opacification and angiogenesis (arrows).
Mice receiving immune cells at 72 hr p.i. and surviving encephalitis, show necrotic
lesions of the central cornea along with angiogenesis at day 25 p.i.
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Figure 5. Inflammatory cells infiltrate corneas of OT-1 RAG-/- mice s bowing
HSK lesions.

Photographs of representative corneas of OT-RAG-/- mice at day 1 2 (A), OT- 1 RAG
/-: CD8 72 hr at day 25 (B) and OT- 1 RAG-/-: 24 hr at day 25 (C). Paraffin embedded
eyes were sectioned and hematoxylin and eosin staining was carried out on 6J..1
sections. Magnification x200.
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Figure 6. C�8+ T cells in corneas and trigeminal ganglia.

Frozen sections (6Jl) of representative eyes of OT- 1 RAG-/- mice day 12 (A) and OT1 RAG-/-: CD8 72 hr day 25 (B) was stained with FITC labeled anti-CD8a MAb.
Propidium iodide was used as a counterstain. Scale Bars: 80Jlm
Frozen sections (6Jl) of eyes of OT- 1 RAG-/-: CD8 72 hr at day 25 p. i. (C) and of
eyes (D) and trigeminal ganglia (E) of OT- 1 RAG-/-: gBT-1. 1 CD8 72 hr at day 1 2 p.
i. were incubated with FITC labeled anti-CD8a (green) and biotin labeled anti
CD45.2. After incubation with streptavidin-Alexa fluor 546 (red), images were
captured using a confocal microscope. The differential interference contrast. (DI(:)
image shows the location of the epithelium (epi) and stroma (str) of the cornea.
Arrows show CD8+CD45.2+ cells. Scale Bars: 80Jlm
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Figure 7. Donor CDS+ T cells in spleens, draining lymph nodes and the nervous
system

Single cell suspensions of spleen, DLN, TG and brain of OT- 1 RAG-/- mice were
analyzed for the presence of donor CD8+ T cells at day 25 and day 1 2 p.i. by flow
cytometry. The ability of the detectable donor CD8s to produce IFNy in response to
the HSV immunodominant CD8 epitope gB49s-sos was measured by intracellular
analysis (see materials and methods). All CD8+ T cells in a naive OT- 1 RAG-/- mouse
were CD45. 1 + and none were CD45.2+ (first row). Figures in the upper right quadrant
of each plot represent the percentage of CD8+ T cells staining with the respective
CD45 marker or intracellular IFNy (for the latter gated on CD8+CD45.2+ cells). Plots
for spleen, DLN and brain represent data from 1 of 3 mice analyzed. Plots for TG
represents data from a pool of 3 TGs.
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